sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	atypical_mitotic_figures	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	clinical_M	ct_scan_findings	cytoplasm_presence_less_than_equal_25_percent	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	diffuse_architecture	distant_metastasis_anatomic_site	excess_adrenal_hormone_diagnosis_method_type	excess_adrenal_hormone_history_type	form_completion_date	gender	germline_testing_performed	histologic_disease_progression_present_indicator	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_weight	invasion_of_tumor_capsule	is_ffpe	laterality	lost_follow_up	lymph_node_examined_count	metastatic_neoplasm_confirmed_diagnosis_method_name	metastatic_neoplasm_confirmed_diagnosis_method_text	mitoses_count	mitotane_therapy	mitotane_therapy_adjuvant_setting	mitotane_therapy_for_macroscopic_residual_disease	mitotic_rate	necrosis	new_neoplasm_confirmed_diagnosis_method_name	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	nuclear_grade_III_IV	number_of_lymphnodes_positive_by_he	oct_embedded	other_dx	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	post_surgical_procedure_assessment_thyroid_gland_carcinoma_stats	postoperative_rx_tx	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	radiation_therapy	residual_tumor	ret	sample_type	sample_type_id	sinusoid_invasion	therapeutic_mitotane_levels_achieved	therapeutic_mitotane_lvl_macroscopic_residual	therapeutic_mitotane_lvl_progression	therapeutic_mitotane_lvl_recurrence	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	weiss_score	weiss_venous_invasion	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_ACC_mutation_curated_bcm_gene	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_percentile	_GENOMIC_ID_data/public/TCGA/ACC/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_ACC_miRNA_HiSeq	_GENOMIC_ID_TCGA_ACC_RPPA	_GENOMIC_ID_TCGA_ACC_hMethyl450	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2	_GENOMIC_ID_TCGA_ACC_gistic2thd	_GENOMIC_ID_TCGA_ACC_PDMRNAseq	_GENOMIC_ID_TCGA_ACC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_ACC_gistic2	_GENOMIC_ID_TCGA_ACC_mutation_bcm_gene	_GENOMIC_ID_TCGA_ACC_mutation_curated_broad_gene
TCGA-OR-A5J1-01	1	TCGA-OR-A5J1-01	1355	1	days	TCGA-OR-A5J1	754	1	days	1355	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	NO	NO	58	Atypical Mitotic Figures Absent	TCGA-OR-A5J1-F60566	TCGA-OR-A5J1	TCGA-OR-A5J1-01A	M0		Cytoplasm presence <= 25% Present	-21496	4691	1355	0			754	Diffuse Architecture Present			Mineralocorticoids	2014-6-11	MALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Left	NO				5	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Imaging	Peritoneal Surfaces	Distant Metastasis		NO	YES	Nuclear Grade III or IV Absent		true	No	N0	T2	Stage II	TCGA-OR-A5J1.8866FD87-4F6F-4D7E-B99A-7DD427ED3BB3.pdf	A5J1	WITH TUMOR	Persistent distant metastases	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2000	TCGA-OR-A5J1-01A-11D-A29I-10	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01	TCGA-OR-A5J1-01		TCGA-OR-A5J1-01A-11D-A29J-05	37e88158-0743-45b8-87cf-1d7fe878527f	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01A-11D-A29H-01	TCGA-OR-A5J1-01	TCGA-OR-A5J1-01	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01A-11D-A29H-01	TCGA-OR-A5J1-01A-11D-A29I-10	TCGA-OR-A5J1-01A-11D-A29I-10
TCGA-OR-A5J2-01	1	TCGA-OR-A5J2-01	1677	1	days	TCGA-OR-A5J2			days	1677	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			44	Atypical Mitotic Figures Present		TCGA-OR-A5J2	TCGA-OR-A5J2-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-16090	3124	1677	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2013-12-3	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	350	Invasion of Tumor Capsule Present	NO	Left		1	Imaging Suspected		0	YES		YES	Mitotic Rate > 5/50 HPF Absent	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage IV	TCGA-OR-A5J2.345C34EE-F031-41A4-B955-BA054F2A3CE1.pdf	A5J2	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2004	TCGA-OR-A5J2-01A-11D-A29I-10	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01	TCGA-OR-A5J2-01	F9762BBB-BCA0-4B54-A2C8-6F81A91DE22F	TCGA-OR-A5J2-01A-11D-A29J-05	421bbd6b-fb2a-4a6d-a298-057c1b65f041	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01A-11D-A29H-01	TCGA-OR-A5J2-01	TCGA-OR-A5J2-01	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01A-11D-A29H-01	TCGA-OR-A5J2-01A-11D-A29I-10	TCGA-OR-A5J2-01A-11D-A29I-10
TCGA-OR-A5J3-01	0	TCGA-OR-A5J3-01	2091	0	days	TCGA-OR-A5J3	1149	1	days	2091	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	23	Atypical Mitotic Figures Absent	TCGA-OR-A5J3-F59590	TCGA-OR-A5J3	TCGA-OR-A5J3-01A	M0	Vena Cava Involvement/thrombus	Cytoplasm presence <= 25% Present	-8624	1584		0	2091	1583	1149	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-15	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	310	Invasion of Tumor Capsule Absent	NO	Left	NO	4			6	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage III	TCGA-OR-A5J3.83F53610-4F40-425B-9B69-BBB94234224F.pdf	A5J3	WITH TUMOR	No imaging evidence of disease	NO	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2008	TCGA-OR-A5J3-01A-11D-A29I-10	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01	TCGA-OR-A5J3-01	21AB5BC5-D822-4C70-BAD0-1E390A55456E	TCGA-OR-A5J3-01A-11D-A29J-05	83b02107-0c7c-450d-84aa-9ed4e1d755c5	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01A-11D-A29H-01	TCGA-OR-A5J3-01	TCGA-OR-A5J3-01	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01A-11D-A29H-01	TCGA-OR-A5J3-01A-11D-A29I-10	TCGA-OR-A5J3-01A-11D-A29I-10
TCGA-OR-A5J4-01	1	TCGA-OR-A5J4-01	423	1	days	TCGA-OR-A5J4			days	423	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			23	Atypical Mitotic Figures Absent		TCGA-OR-A5J4		M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-8451		423	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-12-2	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Right		2	Imaging Suspected		77	YES		YES	Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present	2		No	N1	T3	Stage IV		A5J4	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal		DECEASED	6	Venous Invasion Present	2000	TCGA-OR-A5J4-01A-11D-A29I-10		TCGA-OR-A5J4-01	TCGA-OR-A5J4-01		TCGA-OR-A5J4-01A-11D-A29J-05			TCGA-OR-A5J4-01A-11D-A29H-01				TCGA-OR-A5J4-01A-11D-A29H-01	TCGA-OR-A5J4-01A-11D-A29I-10	TCGA-OR-A5J4-01A-11D-A29I-10
TCGA-OR-A5J5-01	1	TCGA-OR-A5J5-01	365	1	days	TCGA-OR-A5J5			days	365	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			30	Atypical Mitotic Figures Present		TCGA-OR-A5J5		M0	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Absent	-11171		365	0				Diffuse Architecture Absent			None	2013-12-3	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Right					3	YES		YES	Mitotic Rate > 5/50 HPF Absent	Necrosis Present						YES	Nuclear Grade III or IV Present			No	N0	T4	Stage III		A5J5	WITH TUMOR	Persistent locoregional disease	YES	NO	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		DECEASED	6	Venous Invasion Present	2000	TCGA-OR-A5J5-01A-11D-A29I-10	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01	TCGA-OR-A5J5-01		TCGA-OR-A5J5-01A-11D-A29J-05	f72bfbe6-411d-412e-aaab-1a2414e544ec	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01A-11D-A29H-01	TCGA-OR-A5J5-01	TCGA-OR-A5J5-01	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01A-11D-A29H-01	TCGA-OR-A5J5-01A-11D-A29I-10	TCGA-OR-A5J5-01A-11D-A29I-10
TCGA-OR-A5J6-01	0	TCGA-OR-A5J6-01	2703	0	days	TCGA-OR-A5J6	2703	0	days	2703	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			29	Atypical Mitotic Figures Absent	TCGA-OR-A5J6-F59329	TCGA-OR-A5J6	TCGA-OR-A5J6-01A	M0	Normal	Cytoplasm presence <= 25% Present	-10839	2220		0	2703			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-8	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	340	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	No	N0	T2	Stage II	TCGA-OR-A5J6.F664D25E-9050-460D-AEAE-AA4BFA515453.pdf	A5J6	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2006	TCGA-OR-A5J6-01A-31D-A29I-10	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01	TCGA-OR-A5J6-01	BBE6AF7B-BCDD-4179-94E2-2978AF7A03A4	TCGA-OR-A5J6-01A-31D-A29J-05	bb6e0e73-ff48-4627-bce6-f672c06b7de4	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01A-31D-A29H-01	TCGA-OR-A5J6-01	TCGA-OR-A5J6-01	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01A-31D-A29H-01	TCGA-OR-A5J6-01A-31D-A29I-10	TCGA-OR-A5J6-01A-31D-A29I-10
TCGA-OR-A5J7-01	1	TCGA-OR-A5J7-01	490	1	days	TCGA-OR-A5J7			days	490	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			30	Atypical Mitotic Figures Present		TCGA-OR-A5J7	TCGA-OR-A5J7-01A	M0	Normal	Cytoplasm presence <= 25% Present	-11279	1388	490	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-12-2	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right		1			3	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage III	TCGA-OR-A5J7.F9C1971C-5BE2-4722-9A6C-CF4A4AD04352.pdf	A5J7	WITH TUMOR	No imaging evidence of disease	YES	YES	Progressive Disease	NO	R1		Primary Tumor	01	Sinusoid Invasion Absent	NO				NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Present	2009	TCGA-OR-A5J7-01A-11D-A29I-10	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01	TCGA-OR-A5J7-01	C89548B7-83CE-40C3-A25C-DE98CEE4415D	TCGA-OR-A5J7-01A-11D-A29J-05	59eb3b91-d706-45de-9bbe-92b32629c58c	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01A-11D-A29H-01	TCGA-OR-A5J7-01	TCGA-OR-A5J7-01	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01A-11D-A29H-01	TCGA-OR-A5J7-01A-11D-A29I-10	TCGA-OR-A5J7-01A-11D-A29I-10
TCGA-OR-A5J8-01	1	TCGA-OR-A5J8-01	579	1	days	TCGA-OR-A5J8			days	579	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			66	Atypical Mitotic Figures Present		TCGA-OR-A5J8	TCGA-OR-A5J8-01A	M0	Normal	Cytoplasm presence <= 25% Present	-24266	396	579	0				Diffuse Architecture Present		Biochemical Assessment	Cortisol	2013-12-3	MALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left		1			15	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage III	TCGA-OR-A5J8.EA68CD7A-9308-40CD-BB52-CEB36334A146.pdf	A5J8	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO			NO	NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2011	TCGA-OR-A5J8-01A-11D-A29I-10	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01	TCGA-OR-A5J8-01	8D7AD90D-2927-4106-8DB3-C1F9BA8A6A15	TCGA-OR-A5J8-01A-11D-A29J-05	73fee5d0-d326-484c-95c6-c40c987c6917	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01A-11D-A29H-01	TCGA-OR-A5J8-01	TCGA-OR-A5J8-01	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01A-11D-A29H-01	TCGA-OR-A5J8-01A-11D-A29I-10	TCGA-OR-A5J8-01A-11D-A29I-10
TCGA-OR-A5J9-01	0	TCGA-OR-A5J9-01	1352	0	days	TCGA-OR-A5J9	414	1	days	1352	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	NO	NO	22	Atypical Mitotic Figures Absent	TCGA-OR-A5J9-F59596	TCGA-OR-A5J9	TCGA-OR-A5J9-01A	M0	Normal	Cytoplasm presence <= 25% Present	-8175	849		0	1352		414	Diffuse Architecture Present			None	2014-5-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Absent	NO	Right	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5J9.4C775CF4-39D7-4246-87A4-4659783A1C18.pdf	A5J9	WITH TUMOR	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2010	TCGA-OR-A5J9-01A-11D-A29I-10	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01	TCGA-OR-A5J9-01	E058CA44-9D1C-40F2-98D1-BC8A31CC4713	TCGA-OR-A5J9-01A-11D-A29J-05	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01A-11D-A29H-01	TCGA-OR-A5J9-01	TCGA-OR-A5J9-01	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01A-11D-A29H-01	TCGA-OR-A5J9-01A-11D-A29I-10	TCGA-OR-A5J9-01A-11D-A29I-10
TCGA-OR-A5JA-01	1	TCGA-OR-A5JA-01	922	1	days	TCGA-OR-A5JA	922	0	days	922	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			53	Atypical Mitotic Figures Present		TCGA-OR-A5JA	TCGA-OR-A5JA-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-19436	2931	922	0				Diffuse Architecture Present	Retroperitoneum	Both Clinical and Biochemical Assessments	Androgen	2013-9-17	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Right			Imaging Suspected		90	NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T4	Stage IV	TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66.pdf	A5JA	WITH TUMOR	Persistent distant metastases	YES	NO		NO	R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2004	TCGA-OR-A5JA-01A-11D-A29I-10	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01	TCGA-OR-A5JA-01	969F9640-F208-4C28-91AE-AD429932EC1F	TCGA-OR-A5JA-01A-11D-A29J-05	d979c964-68e1-4ea4-a473-69b69cba8e5c	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01A-11D-A29H-01	TCGA-OR-A5JA-01	TCGA-OR-A5JA-01	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01A-11D-A29H-01	TCGA-OR-A5JA-01A-11D-A29I-10	TCGA-OR-A5JA-01A-11D-A29I-10
TCGA-OR-A5JB-01	1	TCGA-OR-A5JB-01	551	1	days	TCGA-OR-A5JB			days	551	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			52	Atypical Mitotic Figures Present		TCGA-OR-A5JB	TCGA-OR-A5JB-01A	M1		Cytoplasm presence <= 25% Present	-19172	4678	551	0				Diffuse Architecture Present	brain		None	2013-9-17	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Present	NO	Right			Other, specify	excision of brain met	15				Mitotic Rate > 5/50 HPF Present	Necrosis Present							Nuclear Grade III or IV Present		true	No	N0	T4	Stage IV	TCGA-OR-A5JB.81022A25-6D64-419D-9B97-22348E17ECEA.pdf	A5JB		Persistent distant metastases					R1		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	7	Venous Invasion Absent	2000	TCGA-OR-A5JB-01A-11D-A29I-10	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01	TCGA-OR-A5JB-01		TCGA-OR-A5JB-01A-11D-A29J-05	26861b93-29de-42df-80d6-23260d450391	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01A-11D-A29H-01	TCGA-OR-A5JB-01	TCGA-OR-A5JB-01	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01A-11D-A29H-01	TCGA-OR-A5JB-01A-11D-A29I-10	TCGA-OR-A5JB-01A-11D-A29I-10
TCGA-OR-A5JC-01	1	TCGA-OR-A5JC-01	1750	1	days	TCGA-OR-A5JC			days	1750	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			37	Atypical Mitotic Figures Present		TCGA-OR-A5JC				Cytoplasm presence <= 25% Present	-13862		1750	0				Diffuse Architecture Present		Biochemical Assessment	Estrogen	2013-9-17	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Left					24				Mitotic Rate > 5/50 HPF Present	Necrosis Present							Nuclear Grade III or IV Present			No					A5JC				NO					Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		DECEASED	8	Venous Invasion Present	2001	TCGA-OR-A5JC-01A-11D-A29I-10	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01	TCGA-OR-A5JC-01		TCGA-OR-A5JC-01A-11D-A29J-05	c51255ac-840d-44c2-87ae-ed91cc635e85	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01A-11D-A29H-01	TCGA-OR-A5JC-01	TCGA-OR-A5JC-01	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01A-11D-A29H-01	TCGA-OR-A5JC-01A-11D-A29I-10	TCGA-OR-A5JC-01A-11D-A29I-10
TCGA-OR-A5JD-01	0	TCGA-OR-A5JD-01	3038	0	days	TCGA-OR-A5JD	3038	0	days	3038	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			57	Atypical Mitotic Figures Absent	TCGA-OR-A5JD-F71752	TCGA-OR-A5JD	TCGA-OR-A5JD-01A	M0		Cytoplasm presence <= 25% Present	-20989	2571		0	3038			Diffuse Architecture Present			None	2015-3-30	FEMALE	NO		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Left	NO				4		NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5JD.AA05D1FB-38B5-4D96-B9EE-07523C95C481.pdf	A5JD	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2005	TCGA-OR-A5JD-01A-11D-A29I-10	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01	TCGA-OR-A5JD-01		TCGA-OR-A5JD-01A-11D-A29J-05	8067d29d-a249-42b9-bd9e-de47513a4230	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01A-11D-A29H-01	TCGA-OR-A5JD-01	TCGA-OR-A5JD-01	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01A-11D-A29H-01	TCGA-OR-A5JD-01A-11D-A29I-10	TCGA-OR-A5JD-01A-11D-A29I-10
TCGA-OR-A5JE-01	1	TCGA-OR-A5JE-01	2105	1	days	TCGA-OR-A5JE			days	2105	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			17	Atypical Mitotic Figures Present		TCGA-OR-A5JE	TCGA-OR-A5JE-01A	M0		Cytoplasm presence <= 25% Present	-6455	2703	2105	0				Diffuse Architecture Present		Biochemical Assessment	Cortisol	2013-9-17	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Present	NO	Left					60	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present		true	No	N0	T1	Stage I	TCGA-OR-A5JE.80EDB29A-262A-486D-B31A-EA015FA8A362.pdf	A5JE	WITH TUMOR		YES			NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Absent	2005	TCGA-OR-A5JE-01A-11D-A29I-10	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01	TCGA-OR-A5JE-01		TCGA-OR-A5JE-01A-11D-A29J-05	223e2af0-95a2-49f2-84a2-13379cf72ea9	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01A-11D-A29H-01	TCGA-OR-A5JE-01	TCGA-OR-A5JE-01	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01A-11D-A29H-01	TCGA-OR-A5JE-01A-11D-A29I-10	TCGA-OR-A5JE-01A-11D-A29I-10
TCGA-OR-A5JF-01	0	TCGA-OR-A5JF-01	2015	0	days	TCGA-OR-A5JF	2015	0	days	2015	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			69	Atypical Mitotic Figures Present	TCGA-OR-A5JF-F60581	TCGA-OR-A5JF		M0		Cytoplasm presence <= 25% Present	-25502			0	2015			Diffuse Architecture Absent		Biochemical Assessment	Cortisol	2014-6-11	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Left	NO				4	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present			No	N0	T2	Stage II		A5JF	TUMOR FREE	No imaging evidence of disease	YES		Complete Remission/Response	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal		LIVING	4	Venous Invasion Absent	2007	TCGA-OR-A5JF-01A-11D-A29I-10	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01	TCGA-OR-A5JF-01		TCGA-OR-A5JF-01A-11D-A29J-05	ba350477-3c49-4258-8409-f39447687497	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01A-11D-A29H-01	TCGA-OR-A5JF-01	TCGA-OR-A5JF-01	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01A-11D-A29H-01	TCGA-OR-A5JF-01A-11D-A29I-10	TCGA-OR-A5JF-01A-11D-A29I-10
TCGA-OR-A5JG-01	1	TCGA-OR-A5JG-01	541	1	days	TCGA-OR-A5JG			days	541	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			61	Atypical Mitotic Figures Present		TCGA-OR-A5JG	TCGA-OR-A5JG-01A	M1	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Present	-22390	1771	541	0				Diffuse Architecture Present	left cervical lymph node	Both Clinical and Biochemical Assessments	Cortisol	2013-10-3	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left		8			100	YES			Mitotic Rate > 5/50 HPF Present	Necrosis Present							Nuclear Grade III or IV Present	6	true	No	N1	T4	Stage IV	TCGA-OR-A5JG.15F6D8D6-878A-410F-8289-D3CEAB7E5D21.pdf	A5JG	WITH TUMOR	Persistent distant metastases	YES	YES			R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2008	TCGA-OR-A5JG-01A-11D-A29I-10	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01	TCGA-OR-A5JG-01		TCGA-OR-A5JG-01A-11D-A29J-05	60c8c1da-fea6-41f7-ba5b-33afba1ef301	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01A-11D-A29H-01	TCGA-OR-A5JG-01	TCGA-OR-A5JG-01	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01A-11D-A29H-01	TCGA-OR-A5JG-01A-11D-A29I-10	TCGA-OR-A5JG-01A-11D-A29I-10
TCGA-OR-A5JH-01	0	TCGA-OR-A5JH-01	2110	0	days	TCGA-OR-A5JH	2110	0	days	2110	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			32	Atypical Mitotic Figures Absent	TCGA-OR-A5JH-F60573	TCGA-OR-A5JH	TCGA-OR-A5JH-01A	M0		Cytoplasm presence <= 25% Present	-11994	1811		0	2110			Diffuse Architecture Present			None	2014-6-11	FEMALE	NO		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Absent	NO	Left	NO				1		NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5JH.CF498A30-11FC-4F20-A424-E3A1216D54B2.pdf	A5JH	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	4	Venous Invasion Absent	2008	TCGA-OR-A5JH-01A-11D-A30A-10								TCGA-OR-A5JH-01A-11D-A309-01				TCGA-OR-A5JH-01A-11D-A309-01	TCGA-OR-A5JH-01A-11D-A30A-10	TCGA-OR-A5JH-01A-11D-A30A-10
TCGA-OR-A5JI-01	0	TCGA-OR-A5JI-01	2331	0	days	TCGA-OR-A5JI	2331	0	days	2331	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			22	Atypical Mitotic Figures Absent	TCGA-OR-A5JI-F71753	TCGA-OR-A5JI		M0	Normal	Cytoplasm presence <= 25% Present	-8177			0	2331			Diffuse Architecture Present			None	2015-3-30	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Right	NO				1	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present			No	N0	T1	Stage I		A5JI	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal		LIVING	3	Venous Invasion Absent	2008	TCGA-OR-A5JI-01A-11D-A29I-10	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01	TCGA-OR-A5JI-01		TCGA-OR-A5JI-01A-11D-A29J-05	d5a1b1c5-f790-4733-a8f5-09372d695688	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01A-11D-A29H-01	TCGA-OR-A5JI-01	TCGA-OR-A5JI-01	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01A-11D-A29H-01	TCGA-OR-A5JI-01A-11D-A29I-10	TCGA-OR-A5JI-01A-11D-A29I-10
TCGA-OR-A5JJ-01	1	TCGA-OR-A5JJ-01	490	1	days	TCGA-OR-A5JJ	490	0	days	490	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			65	Atypical Mitotic Figures Present	TCGA-OR-A5JJ-F60575	TCGA-OR-A5JJ	TCGA-OR-A5JJ-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-24082	1308	490	0	309			Diffuse Architecture Present			None	2014-6-11	MALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Present	NO	Left	NO	6			50	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present	6	true	No	N1	T4	Stage IV	TCGA-OR-A5JJ.AF7A85AB-4C73-40B8-B913-9E540FEDE0FC.pdf	A5JJ	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Present	NO				NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2009	TCGA-OR-A5JJ-01A-11D-A29I-10	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01	TCGA-OR-A5JJ-01		TCGA-OR-A5JJ-01A-11D-A29J-05	39336e11-24de-43be-913a-c764310d1eee	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01A-11D-A29H-01	TCGA-OR-A5JJ-01	TCGA-OR-A5JJ-01	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01A-11D-A29H-01	TCGA-OR-A5JJ-01A-11D-A29I-10	TCGA-OR-A5JJ-01A-11D-A29I-10
TCGA-OR-A5JK-01	0	TCGA-OR-A5JK-01	1497	0	days	TCGA-OR-A5JK	1497	0	days	1497	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			49	Atypical Mitotic Figures Present	TCGA-OR-A5JK-F60576	TCGA-OR-A5JK		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-18214			0	1497			Diffuse Architecture Present			None	2014-6-11	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Left	NO		Biopsy Proven		4	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present			No	N0	T4	Stage IV		A5JK	TUMOR FREE	Persistent distant metastases	YES		Partial Remission/Response	YES	R2		Primary Tumor	01	Sinusoid Invasion Present	YES				NO	YES	OR	Adrenal		LIVING	8	Venous Invasion Present	2009	TCGA-OR-A5JK-01A-11D-A29I-10	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01	TCGA-OR-A5JK-01		TCGA-OR-A5JK-01A-11D-A29J-05	db5bc4cb-f0bc-4c26-bd11-1bf918466263	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01A-11D-A29H-01	TCGA-OR-A5JK-01	TCGA-OR-A5JK-01	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01A-11D-A29H-01	TCGA-OR-A5JK-01A-11D-A29I-10	TCGA-OR-A5JK-01A-11D-A29I-10
TCGA-OR-A5JL-01	0	TCGA-OR-A5JL-01	2056	0	days	TCGA-OR-A5JL	2056	0	days	2056	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			36	Atypical Mitotic Figures Present	TCGA-OR-A5JL-F71754	TCGA-OR-A5JL	TCGA-OR-A5JL-01A	M0	Normal	Cytoplasm presence <= 25% Present	-13155	1224		0	2056			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2015-3-30	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Right	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	No	N0	T1	Stage I	TCGA-OR-A5JL.BD8435C3-C525-472C-8B43-EC2CAE22B785.pdf	A5JL	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2009	TCGA-OR-A5JL-01A-11D-A29I-10	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01	TCGA-OR-A5JL-01		TCGA-OR-A5JL-01A-11D-A29J-05	3e28c232-4f00-446e-8e2c-13b7ce533442	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01A-11D-A29H-01	TCGA-OR-A5JL-01	TCGA-OR-A5JL-01	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01A-11D-A29H-01	TCGA-OR-A5JL-01A-11D-A29I-10	TCGA-OR-A5JL-01A-11D-A29I-10
TCGA-OR-A5JM-01	1	TCGA-OR-A5JM-01	562	1	days	TCGA-OR-A5JM			days	562	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			25	Atypical Mitotic Figures Present		TCGA-OR-A5JM	TCGA-OR-A5JM-01A	M1	Liver Involvement	Cytoplasm presence <= 25% Present	-9359	657	562	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-10-3	FEMALE	NO		Adrenocortical carcinoma- Usual Type	Yes	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Left			Other, specify		90	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present		true	No	N0	T4	Stage IV	TCGA-OR-A5JM.A214150E-54BD-499D-A56D-082BAC861668.pdf	A5JM	WITH TUMOR	Biochemical Evidence of Disease	YES		Progressive Disease	YES	R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2011	TCGA-OR-A5JM-01A-11D-A29I-10	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01	TCGA-OR-A5JM-01		TCGA-OR-A5JM-01A-11D-A29J-05	908285b8-1e2e-4aed-86df-2aaeb1bcefea	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01A-11D-A29H-01	TCGA-OR-A5JM-01	TCGA-OR-A5JM-01	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01A-11D-A29H-01	TCGA-OR-A5JM-01A-11D-A29I-10	TCGA-OR-A5JM-01A-11D-A29I-10
TCGA-OR-A5JO-01	0	TCGA-OR-A5JO-01	1194	0	days	TCGA-OR-A5JO	1194	0	days	1194	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			26	Atypical Mitotic Figures Absent	TCGA-OR-A5JO-F71755	TCGA-OR-A5JO		M0	Normal	Cytoplasm presence <= 25% Absent	-9547			0	1194			Diffuse Architecture Present			None	2015-3-30	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Right	NO				2	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present			No	N0	T1	Stage I		A5JO	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal		LIVING	3	Venous Invasion Present	2005	TCGA-OR-A5JO-01A-11D-A29I-10	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01	TCGA-OR-A5JO-01		TCGA-OR-A5JO-01A-11D-A29J-05	ebc120e7-d75d-425a-b9af-aa0e76520642	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01A-11D-A29H-01	TCGA-OR-A5JO-01	TCGA-OR-A5JO-01	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01A-11D-A29H-01	TCGA-OR-A5JO-01A-11D-A29I-10	TCGA-OR-A5JO-01A-11D-A29I-10
TCGA-OR-A5JP-01	0	TCGA-OR-A5JP-01	464	0	days	TCGA-OR-A5JP	464	0	days	464	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			40	Atypical Mitotic Figures Present	TCGA-OR-A5JP-F60579	TCGA-OR-A5JP	TCGA-OR-A5JP-01A	M0	Normal	Cytoplasm presence <= 25% Present	-14667	289		0	464			Diffuse Architecture Present			None	2014-6-11	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Left	NO				13	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5JP.E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46.pdf	A5JP	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2012	TCGA-OR-A5JP-01A-11D-A29I-10	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01	TCGA-OR-A5JP-01	FD2E1526-5455-40FA-8AE2-15C5FF2BAA65	TCGA-OR-A5JP-01A-11D-A29J-05	49e3ffbc-f75f-4f3d-99de-12c29ef69154	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01A-11D-A29H-01	TCGA-OR-A5JP-01	TCGA-OR-A5JP-01	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01A-11D-A29H-01	TCGA-OR-A5JP-01A-11D-A29I-10	TCGA-OR-A5JP-01A-11D-A29I-10
TCGA-OR-A5JQ-01	0	TCGA-OR-A5JQ-01	1103	0	days	TCGA-OR-A5JQ	1103	0	days	1103	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			26	Atypical Mitotic Figures Absent	TCGA-OR-A5JQ-F60580	TCGA-OR-A5JQ		M0	Normal	Cytoplasm presence <= 25% Present	-9667			0	1103			Diffuse Architecture Present			None	2014-6-11	FEMALE	NO		Adrenocortical Carcinoma- Myxoid Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Right	NO				3	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present			No	N0	T2	Stage II		A5JQ	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		LIVING	4	Venous Invasion Absent	2006	TCGA-OR-A5JQ-01A-11D-A29I-10	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01	TCGA-OR-A5JQ-01		TCGA-OR-A5JQ-01A-11D-A29J-05	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01A-11D-A29H-01	TCGA-OR-A5JQ-01	TCGA-OR-A5JQ-01	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01A-11D-A29H-01	TCGA-OR-A5JQ-01A-11D-A29I-10	TCGA-OR-A5JQ-01A-11D-A29I-10
TCGA-OR-A5JR-01	0	TCGA-OR-A5JR-01	3688	0	days	TCGA-OR-A5JR	3688	0	days	3688	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			45		TCGA-OR-A5JR-F59158	TCGA-OR-A5JR	TCGA-OR-A5JR-01A	M0			-16604	3751		0	3688			Diffuse Architecture Absent			None	2014-5-2	MALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Left	YES					NO				Necrosis Absent						NO	Nuclear Grade III or IV Absent		false	No	N0	T1	Stage I	TCGA-OR-A5JR.33E0DEF4-2538-4C8B-A71C-11B4F9D57E32.pdf	A5JR	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2002	TCGA-OR-A5JR-01A-11D-A29I-10	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01	TCGA-OR-A5JR-01	8DCC0B31-4CD4-4537-8BC1-C928F1E5BB29	TCGA-OR-A5JR-01A-11D-A29J-05	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01A-11D-A29H-01	TCGA-OR-A5JR-01	TCGA-OR-A5JR-01	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01A-11D-A29H-01	TCGA-OR-A5JR-01A-11D-A29I-10	TCGA-OR-A5JR-01A-11D-A29I-10
TCGA-OR-A5JS-01	0	TCGA-OR-A5JS-01	383	0	days	TCGA-OR-A5JS	166	1	days	383	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	65		TCGA-OR-A5JS-F59160	TCGA-OR-A5JS	TCGA-OR-A5JS-01A	M0	Normal		-24017	699		0	383		166				None	2014-5-2	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	150	Invasion of Tumor Capsule Absent	NO	Right	YES				35	NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES			false	No	N0	T2	Stage II	TCGA-OR-A5JS.B6E65697-5AE8-45B4-9FAA-D25B8F57988F.pdf	A5JS	WITH TUMOR	No imaging evidence of disease	NO	NO		YES	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2011	TCGA-OR-A5JS-01A-11D-A29I-10	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01	TCGA-OR-A5JS-01	D187AC75-482F-454F-851A-10A7ABEBA2BF	TCGA-OR-A5JS-01A-11D-A29J-05	68b2e310-e0a0-4867-b9cf-69b43cbdabce	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01A-11D-A29H-01	TCGA-OR-A5JS-01	TCGA-OR-A5JS-01	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01A-11D-A29H-01	TCGA-OR-A5JS-01A-11D-A29I-10	TCGA-OR-A5JS-01A-11D-A29I-10
TCGA-OR-A5JT-01	0	TCGA-OR-A5JT-01	907	0	days	TCGA-OR-A5JT	907	0	days	907	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			65		TCGA-OR-A5JT-F59161	TCGA-OR-A5JT	TCGA-OR-A5JT-01A	M0	Normal		-23794	419		0	907					Biochemical Assessment	Cortisol	2014-5-1	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	140	Invasion of Tumor Capsule Absent	NO	Left	NO	17			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO		0	false	No	N0	T2	Stage II	TCGA-OR-A5JT.095AE671-9808-4895-B6FD-EDA3F7F9E69D.pdf	A5JT	WITH TUMOR	No imaging evidence of disease	YES	YES	Stable Disease	YES	R0		Primary Tumor	01		YES			YES	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2011	TCGA-OR-A5JT-01A-11D-A29I-10	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01	TCGA-OR-A5JT-01	C9D2DE61-07C2-4BE8-832F-D4D95749A075	TCGA-OR-A5JT-01A-11D-A29J-05	36c36f8f-d15b-43be-a285-1f80fcfff555	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01A-11D-A29H-01	TCGA-OR-A5JT-01	TCGA-OR-A5JT-01	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01A-11D-A29H-01	TCGA-OR-A5JT-01A-11D-A29I-10	TCGA-OR-A5JT-01A-11D-A29I-10
TCGA-OR-A5JU-01	1	TCGA-OR-A5JU-01	289	1	days	TCGA-OR-A5JU			days	289	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			58			TCGA-OR-A5JU	TCGA-OR-A5JU-01A	M0	Normal		-21292	749	289	0							None	2014-2-6	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Right					10	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	Necrosis Absent						YES			false	No	N0	T3	Stage III	TCGA-OR-A5JU.2D791779-66E6-408C-B479-CC74246F0EA8.pdf	A5JU	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	YES	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Absent	2010	TCGA-OR-A5JU-01A-11D-A30A-10								TCGA-OR-A5JU-01A-11D-A309-01				TCGA-OR-A5JU-01A-11D-A309-01	TCGA-OR-A5JU-01A-11D-A30A-10	TCGA-OR-A5JU-01A-11D-A30A-10
TCGA-OR-A5JV-01	0	TCGA-OR-A5JV-01	2023	0	days	TCGA-OR-A5JV	2023	0	days	2023	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			55		TCGA-OR-A5JV-F59162	TCGA-OR-A5JV	TCGA-OR-A5JV-01A	M0	Normal		-20319	1696		0	2023						None	2014-5-1	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left	NO	1				YES	YES			Necrosis Absent						NO		0	false	No	N0	T2	Stage II	TCGA-OR-A5JV.35A41AE5-44E3-45D1-A2C0-523496732A75.pdf	A5JV	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2008	TCGA-OR-A5JV-01A-11D-A29I-10	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01	TCGA-OR-A5JV-01	148E70D8-63E9-421C-9D54-EB905B6EE954	TCGA-OR-A5JV-01A-11D-A29J-05	20938e21-2846-4553-98eb-6b005b6600c3	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01A-11D-A29H-01	TCGA-OR-A5JV-01	TCGA-OR-A5JV-01	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01A-11D-A29H-01	TCGA-OR-A5JV-01A-11D-A29I-10	TCGA-OR-A5JV-01A-11D-A29I-10
TCGA-OR-A5JW-01	0	TCGA-OR-A5JW-01	2202	0	days	TCGA-OR-A5JW	2202	0	days	2202	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			47		TCGA-OR-A5JW-F59163	TCGA-OR-A5JW	TCGA-OR-A5JW-01A	M0	Normal		-17513	1713		0	2202					Both Clinical and Biochemical Assessments	Cortisol	2014-5-1	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	140		NO	Right	NO					YES	YES			Necrosis Present						NO			false	No	N0	T2	Stage II	TCGA-OR-A5JW.54BAF12C-F096-4415-BFF0-DD35D22E932B.pdf	A5JW	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	YES	R0		Primary Tumor	01		YES				NO	YES	OR	Adrenal	A	LIVING			2008	TCGA-OR-A5JW-01A-11D-A29I-10	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01	TCGA-OR-A5JW-01	7ABAE497-21E0-4DA6-B835-5E60E4E2878F	TCGA-OR-A5JW-01A-11D-A29J-05	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01A-11D-A29H-01	TCGA-OR-A5JW-01	TCGA-OR-A5JW-01	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01A-11D-A29H-01	TCGA-OR-A5JW-01A-11D-A29I-10	TCGA-OR-A5JW-01A-11D-A29I-10
TCGA-OR-A5JX-01	0	TCGA-OR-A5JX-01	950	0	days	TCGA-OR-A5JX	950	0	days	950	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			50		TCGA-OR-A5JX-F59164	TCGA-OR-A5JX	TCGA-OR-A5JX-01A	M0			-18402	1162		0	950						None	2014-5-2	MALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left	YES	1			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO		0	false	No	N0	T3	Stage III	TCGA-OR-A5JX.6F548B5E-C4A2-46C7-8B56-7DD037CC49B5.pdf	A5JX	TUMOR FREE	No imaging evidence of disease	YES	YES		YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Present	2009	TCGA-OR-A5JX-01A-11D-A29I-10	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01	TCGA-OR-A5JX-01		TCGA-OR-A5JX-01A-11D-A29J-05	7fae0485-2028-47e3-a3e1-248257fcc02e	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01A-11D-A29H-01	TCGA-OR-A5JX-01	TCGA-OR-A5JX-01	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01A-11D-A29H-01	TCGA-OR-A5JX-01A-11D-A29I-10	TCGA-OR-A5JX-01A-11D-A29I-10
TCGA-OR-A5JY-01	1	TCGA-OR-A5JY-01	552	1	days	TCGA-OR-A5JY			days	552	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			68			TCGA-OR-A5JY	TCGA-OR-A5JY-01A	M1	Vena Cava Involvement/thrombus		-25190	414	552	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-10	FEMALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Present	NO	Right		2	Other, specify	surgical resection	60	YES	NO	YES	Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES		1	false	No	N1	T4	Stage IV	TCGA-OR-A5JY.8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6.pdf	A5JY	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	YES	R2		Primary Tumor	01			NO			NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Present	2011	TCGA-OR-A5JY-01A-31D-A29I-10	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01	TCGA-OR-A5JY-01	A4ABDBE6-DB86-40C9-8E65-E772D0B6AB28	TCGA-OR-A5JY-01A-31D-A29J-05	1fe73f5c-591d-4c55-ae0e-a67afb64f872	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01A-31D-A29H-01	TCGA-OR-A5JY-01	TCGA-OR-A5JY-01	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01A-31D-A29H-01	TCGA-OR-A5JY-01A-31D-A29I-10	TCGA-OR-A5JY-01A-31D-A29I-10
TCGA-OR-A5JZ-01	0	TCGA-OR-A5JZ-01	822	0	days	TCGA-OR-A5JZ	247	1	days	822	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	60		TCGA-OR-A5JZ-F59165	TCGA-OR-A5JZ	TCGA-OR-A5JZ-01A	M0	Normal		-22218	373		0	822		247				None	2014-5-1	MALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Left	NO				5	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Imaging	Liver	Distant Metastasis		NO	YES			false	No	N0	T2	Stage II	TCGA-OR-A5JZ.90A9556D-C417-4FDB-AE1C-7ACB9F60E444.pdf	A5JZ	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	YES	R0		Primary Tumor	01		NO				NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2011	TCGA-OR-A5JZ-01A-11D-A29I-10	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01	TCGA-OR-A5JZ-01	47A9E07A-5319-4550-98C8-B48E1785E8B9	TCGA-OR-A5JZ-01A-11D-A29J-05	efd8ce67-122c-4502-8713-2f4dd768c33d	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01A-11D-A29H-01	TCGA-OR-A5JZ-01	TCGA-OR-A5JZ-01	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01A-11D-A29H-01	TCGA-OR-A5JZ-01A-11D-A29I-10	TCGA-OR-A5JZ-01A-11D-A29I-10
TCGA-OR-A5K0-01	0	TCGA-OR-A5K0-01	1029	0	days	TCGA-OR-A5K0			days	1029	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			69		TCGA-OR-A5K0-F59166	TCGA-OR-A5K0	TCGA-OR-A5K0-01A	M0	Normal		-25400	1097		0	1029					Biochemical Assessment	Cortisol	2014-5-2	FEMALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Present	NO	Left	YES				8	NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES			false	Yes	N0	T2	Stage II	TCGA-OR-A5K0.4E5C6CF0-F346-4ECE-B296-0D2DB4513804.pdf	A5K0	WITH TUMOR	No imaging evidence of disease	NO	NO	Progressive Disease	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2009	TCGA-OR-A5K0-01A-11D-A29I-10	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01	TCGA-OR-A5K0-01	0C923154-7872-4AEE-A56A-085CCD06E6BC	TCGA-OR-A5K0-01A-11D-A29J-05	e1434398-dde0-4855-adc1-24c2956d817a	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01A-11D-A29H-01	TCGA-OR-A5K0-01	TCGA-OR-A5K0-01	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01A-11D-A29H-01	TCGA-OR-A5K0-01A-11D-A29I-10	TCGA-OR-A5K0-01A-11D-A29I-10
TCGA-OR-A5K1-01	0	TCGA-OR-A5K1-01	3289	0	days	TCGA-OR-A5K1	826	1	days	3289	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	NO	YES	48		TCGA-OR-A5K1-F71436	TCGA-OR-A5K1	TCGA-OR-A5K1-01A	M0	Retroperitoneal Lymph Node Involvement		-17596	2513		0	3289	883	826				None	2015-3-25	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	150	Invasion of Tumor Capsule Present	NO	Left	NO					NO	NO				Imaging	Peritoneal Surfaces	Locoregional Recurrence		YES	YES			false	No	N0	T2	Stage II	TCGA-OR-A5K1.54EFE89F-32E0-4E95-A841-728648D9D11E.pdf	A5K1	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	RX		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2006	TCGA-OR-A5K1-01A-11D-A29I-10	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01	TCGA-OR-A5K1-01	3C6CBE32-CF86-40FC-BF24-560A66EF7CC6	TCGA-OR-A5K1-01A-11D-A29J-05	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01A-11D-A29H-01	TCGA-OR-A5K1-01	TCGA-OR-A5K1-01	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01A-11D-A29H-01	TCGA-OR-A5K1-01A-11D-A29I-10	TCGA-OR-A5K1-01A-11D-A29I-10
TCGA-OR-A5K2-01	1	TCGA-OR-A5K2-01	994	1	days	TCGA-OR-A5K2			days	994	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			32			TCGA-OR-A5K2		M0	Normal		-11970		994	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-10	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Right		1	Imaging Suspected		51	YES	YES	YES	Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES		0		No	N0	T4	Stage III		A5K2	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal		DECEASED		Venous Invasion Present	2010		e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01	TCGA-OR-A5K2-01		TCGA-OR-A5K2-01A-11D-A29J-05	e85fc5ec-7838-46c3-8767-a69f765b066d	e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01A-11D-A29H-01	TCGA-OR-A5K2-01	TCGA-OR-A5K2-01	e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01A-11D-A29H-01	TCGA-OR-A5K2-01A-11D-A29I-10	TCGA-OR-A5K2-01A-11D-A29I-10
TCGA-OR-A5K3-01	0	TCGA-OR-A5K3-01	3465	0	days	TCGA-OR-A5K3	3465	0	days	3465	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			53		TCGA-OR-A5K3-F71438	TCGA-OR-A5K3	TCGA-OR-A5K3-01A	M0	Normal		-19375	2646		0	3465						None	2015-3-25	MALE	NO		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Present	NO	Left	NO					NO	NO			Necrosis Present						NO			false	No	N0	T2	Stage II	TCGA-OR-A5K3.718C16E9-A099-4F21-A48E-A97B464A9422.pdf	A5K3	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2005		61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01	TCGA-OR-A5K3-01	08E6497A-47F5-4283-A534-7C04EEC936E9	TCGA-OR-A5K3-01A-11D-A29J-05	61d60013-6ffd-4c08-b03f-a8820db32397	61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01A-11D-A29H-01	TCGA-OR-A5K3-01	TCGA-OR-A5K3-01	61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01A-11D-A29H-01	TCGA-OR-A5K3-01A-11D-A29I-10	TCGA-OR-A5K3-01A-11D-A29I-10
TCGA-OR-A5K4-01	0	TCGA-OR-A5K4-01	1082	0	days	TCGA-OR-A5K4	1082	0	days	1082	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			64		TCGA-OR-A5K4-F71439	TCGA-OR-A5K4	TCGA-OR-A5K4-01A	M0	Vena Cava Involvement/thrombus		-23481	362		0	1082						None	2015-3-25	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Absent	NO	Right	NO				2	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO			false	No	N0	T4	Stage III	TCGA-OR-A5K4.15A731FD-6B89-450D-A02B-A01DA759340A.pdf	A5K4	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	YES	R1		Primary Tumor	01		NO				NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Present	2011	TCGA-OR-A5K4-01A-11D-A29I-10	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01	TCGA-OR-A5K4-01	A2831971-C497-4E23-A84C-B2D64B21E72C	TCGA-OR-A5K4-01A-11D-A29J-05	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01A-11D-A29H-01	TCGA-OR-A5K4-01	TCGA-OR-A5K4-01	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01A-11D-A29H-01	TCGA-OR-A5K4-01A-11D-A29I-10	TCGA-OR-A5K4-01A-11D-A29I-10
TCGA-OR-A5K5-01	1	TCGA-OR-A5K5-01	498	1	days	TCGA-OR-A5K5	108	1	days	498	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	59		TCGA-OR-A5K5-F59170	TCGA-OR-A5K5	TCGA-OR-A5K5-01A	M0	Normal		-21907	34	498	0	253		108			Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-1	FEMALE	YES	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left	NO	20			31	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES		0	false	No	N0	T3	Stage III	TCGA-OR-A5K5.6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C.pdf	A5K5	WITH TUMOR		YES	YES	Progressive Disease	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Present	2012	TCGA-OR-A5K5-01A-11D-A29I-10	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01	TCGA-OR-A5K5-01	D0C57FBD-20EE-4113-A135-7B7617304C0F	TCGA-OR-A5K5-01A-11D-A29J-05	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01A-11D-A29H-01	TCGA-OR-A5K5-01	TCGA-OR-A5K5-01	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01A-11D-A29H-01	TCGA-OR-A5K5-01A-11D-A29I-10	TCGA-OR-A5K5-01A-11D-A29I-10
TCGA-OR-A5K6-01	0	TCGA-OR-A5K6-01	1493	0	days	TCGA-OR-A5K6	391	1	days	1493	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	56	Atypical Mitotic Figures Present	TCGA-OR-A5K6-F61830	TCGA-OR-A5K6	TCGA-OR-A5K6-01A	M0	Normal	Cytoplasm presence <= 25% Present	-20657	946		0	1493	1003	391	Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2014-7-8	FEMALE		YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Absent	NO	Left	NO				7	YES	NO	YES	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Pathology	Liver	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		false	No	N0	T2	Stage II	TCGA-OR-A5K6.CB9B68D7-762B-4828-9479-4ECFE346AB5C.pdf	A5K6	WITH TUMOR	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent		YES	YES		YES	NO	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2010	TCGA-OR-A5K6-01A-11D-A29I-10	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01	TCGA-OR-A5K6-01	1A7C62C2-00E2-415E-9C4F-318297C57ECE	TCGA-OR-A5K6-01A-11D-A29J-05	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01A-11D-A29H-01	TCGA-OR-A5K6-01	TCGA-OR-A5K6-01	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01A-11D-A29H-01	TCGA-OR-A5K6-01A-11D-A29I-10	TCGA-OR-A5K6-01A-11D-A29I-10
TCGA-OR-A5K8-01	0	TCGA-OR-A5K8-01	749	0	days	TCGA-OR-A5K8	749	0	days	749	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			39	Atypical Mitotic Figures Absent	TCGA-OR-A5K8-F59328	TCGA-OR-A5K8	TCGA-OR-A5K8-01A	M0	Normal	Cytoplasm presence <= 25% Absent	-14435	260		0	749			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2014-5-8	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	590	Invasion of Tumor Capsule Present	NO	Right	NO				7	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5K8.1C0D3231-1F36-4645-95D2-C6BFF78734C9.pdf	A5K8	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO				YES	NO	OR	Adrenal	A	LIVING	4	Venous Invasion Absent	2012	TCGA-OR-A5K8-01A-11D-A29I-10	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01	TCGA-OR-A5K8-01	249586F7-DC75-489A-886E-3AECB9FA7B4B	TCGA-OR-A5K8-01A-11D-A29J-05	53390804-e59b-4e73-aee4-89daa7cde164	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01A-11D-A29H-01	TCGA-OR-A5K8-01	TCGA-OR-A5K8-01	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01A-11D-A29H-01	TCGA-OR-A5K8-01A-11D-A29I-10	TCGA-OR-A5K8-01A-11D-A29I-10
TCGA-OR-A5K9-01	1	TCGA-OR-A5K9-01	344	1	days	TCGA-OR-A5K9			days	344	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			61			TCGA-OR-A5K9	TCGA-OR-A5K9-01A	M0			-22596	3864	344	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-11	FEMALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130		NO	Right						YES	YES									YES			false	No	N0	T2	Stage II	TCGA-OR-A5K9.EAC92541-2274-4FB8-B56B-657413EDF0F9.pdf	A5K9	WITH TUMOR	No imaging evidence of disease	NO	NO		NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED			2002	TCGA-OR-A5K9-01A-11D-A29I-10	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01	TCGA-OR-A5K9-01		TCGA-OR-A5K9-01A-11D-A29J-05	48dd74fe-11ff-4514-87b3-1569e9606c73	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01A-11D-A29H-01	TCGA-OR-A5K9-01	TCGA-OR-A5K9-01	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01A-11D-A29H-01	TCGA-OR-A5K9-01A-11D-A29I-10	TCGA-OR-A5K9-01A-11D-A29I-10
TCGA-OR-A5KB-01	0	TCGA-OR-A5KB-01	741	0	days	TCGA-OR-A5KB	214	1	days	741	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	61	Atypical Mitotic Figures Present	TCGA-OR-A5KB-F59331	TCGA-OR-A5KB	TCGA-OR-A5KB-01A	M0	Normal	Cytoplasm presence <= 25% Absent	-22550	355		0	741		214	Diffuse Architecture Present			None	2014-5-8	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left	NO	3			129	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Pathology	Soft Tissue	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5KB.7553DC0B-FD8C-42E9-B38F-65EA954C6BC6.pdf	A5KB	WITH TUMOR	No imaging evidence of disease	YES	YES	Progressive Disease	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	TCGA-OR-A5KB-01A-11D-A30A-10								TCGA-OR-A5KB-01A-11D-A309-01				TCGA-OR-A5KB-01A-11D-A309-01	TCGA-OR-A5KB-01A-11D-A30A-10	TCGA-OR-A5KB-01A-11D-A30A-10
TCGA-OR-A5KO-01	0	TCGA-OR-A5KO-01	1414	0	days	TCGA-OR-A5KO	541	1	days	1414	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	39	Atypical Mitotic Figures Present	TCGA-OR-A5KO-F60521	TCGA-OR-A5KO	TCGA-OR-A5KO-01A	M1	Liver Involvement	Cytoplasm presence <= 25% Present	-14606	1120		0	1414	561	541	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2014-6-10	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Right	NO		Biopsy Proven|Imaging Suspected			YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Pathology	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		true	No	N0	T4	Stage IV	TCGA-OR-A5KO.B9C848FD-453C-4A56-B625-C4C680790D6A.pdf	A5KO	WITH TUMOR	No imaging evidence of disease	YES		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	NO				NO	YES	OR	Adrenal	A	LIVING	9	Venous Invasion Present	2009	TCGA-OR-A5KO-01A-11D-A29I-10	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01	TCGA-OR-A5KO-01	FFAC8C02-F5D7-4291-8A9A-EC07D7B0AAAC	TCGA-OR-A5KO-01A-11D-A29J-05	0ffc0b01-bc1c-4277-8fc4-865590dcc461	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01A-11D-A29H-01	TCGA-OR-A5KO-01	TCGA-OR-A5KO-01	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01A-11D-A29H-01	TCGA-OR-A5KO-01A-11D-A29I-10	TCGA-OR-A5KO-01A-11D-A29I-10
TCGA-OR-A5KP-01	0	TCGA-OR-A5KP-01	2777	0	days	TCGA-OR-A5KP	1250	1	days	2777	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	NO	NO	45	Atypical Mitotic Figures Absent	TCGA-OR-A5KP-F60584	TCGA-OR-A5KP	TCGA-OR-A5KP-01A	M0	Normal	Cytoplasm presence <= 25% Present	-16702	2281		0	2777	1267	1250	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-11	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Left	NO	2				YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Pathology	Liver	Distant Metastasis		YES	YES	Nuclear Grade III or IV Absent	0	true	Yes	N0	T2	Stage II	TCGA-OR-A5KP.C07E8EA7-A221-40F9-9D19-A59DE0E52200.pdf	A5KP	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES				NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2006	TCGA-OR-A5KP-01A-11D-A30A-10								TCGA-OR-A5KP-01A-11D-A309-01				TCGA-OR-A5KP-01A-11D-A309-01	TCGA-OR-A5KP-01A-11D-A30A-10	TCGA-OR-A5KP-01A-11D-A30A-10
TCGA-OR-A5KQ-01	0	TCGA-OR-A5KQ-01	2677	0	days	TCGA-OR-A5KQ	2677	0	days	2677	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			20	Atypical Mitotic Figures Absent	TCGA-OR-A5KQ-F60587	TCGA-OR-A5KQ	TCGA-OR-A5KQ-01A	M0	Normal	Cytoplasm presence <= 25% Present	-7459	2490		0	2677			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Mineralocorticoids	2014-6-11	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5KQ.7ED6314A-1343-47D5-A40D-4B53FA3D33DF.pdf	A5KQ	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2006	TCGA-OR-A5KQ-01A-11D-A30A-10								TCGA-OR-A5KQ-01A-11D-A309-01				TCGA-OR-A5KQ-01A-11D-A309-01	TCGA-OR-A5KQ-01A-11D-A30A-10	TCGA-OR-A5KQ-01A-11D-A30A-10
TCGA-OR-A5KS-01	0	TCGA-OR-A5KS-01	2549	0	days	TCGA-OR-A5KS	2549	0	days	2549	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			72		TCGA-OR-A5KS-F61319	TCGA-OR-A5KS	TCGA-OR-A5KS-01A	M0	Normal		-26404	2425		0	2549						None	2014-6-26	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	120		NO	Left	NO				0	NO	NO			Necrosis Present						NO			true	No	N0	T2	Stage II	TCGA-OR-A5KS.CF5CAAE7-CEA0-4505-A33F-7E7588DB7D7C.pdf	A5KS	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2006	TCGA-OR-A5KS-01A-11D-A30A-10								TCGA-OR-A5KS-01A-11D-A309-01				TCGA-OR-A5KS-01A-11D-A309-01	TCGA-OR-A5KS-01A-11D-A30A-10	TCGA-OR-A5KS-01A-11D-A30A-10
TCGA-OR-A5KT-01	0	TCGA-OR-A5KT-01	2895	0	days	TCGA-OR-A5KT	2099	1	days	2895	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	NO	44	Atypical Mitotic Figures Absent	TCGA-OR-A5KT-F60526	TCGA-OR-A5KT	TCGA-OR-A5KT-01A	M0	Normal	Cytoplasm presence <= 25% Present	-16217	2399		0	2895	2112	2099	Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Absent	NO	Left	NO				1	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Pathology	Other, specify	Distant Metastasis	Pancreas	YES	YES	Nuclear Grade III or IV Absent		true	No	N0	T1	Stage I	TCGA-OR-A5KT.7BE65565-0C63-466C-AE5D-A9B47BB354C9.pdf	A5KT	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	2	Venous Invasion Absent	2006	TCGA-OR-A5KT-01A-11D-A29I-10	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01	TCGA-OR-A5KT-01		TCGA-OR-A5KT-01A-11D-A29J-05	8448744c-2c5f-4a95-b517-5652f6bacc1a	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01A-11D-A29H-01	TCGA-OR-A5KT-01	TCGA-OR-A5KT-01	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01A-11D-A29H-01	TCGA-OR-A5KT-01A-11D-A29I-10	TCGA-OR-A5KT-01A-11D-A29I-10
TCGA-OR-A5KU-01	0	TCGA-OR-A5KU-01	4673	0	days	TCGA-OR-A5KU	4673	0	days	4673	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			37	Atypical Mitotic Figures Absent	TCGA-OR-A5KU-F60523	TCGA-OR-A5KU	TCGA-OR-A5KU-01A	M0	Normal	Cytoplasm presence <= 25% Present	-13559	4543		0	4673			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Mineralocorticoids	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	70	Invasion of Tumor Capsule Absent	NO	Left	NO	1				YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Absent	0	true	No	N0	T2	Stage II	TCGA-OR-A5KU.F9F537ED-3066-4E99-B6D1-112D6C4551F0.pdf	A5KU	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO			NO	NO	YES	OR	Adrenal	A	LIVING	2	Venous Invasion Absent	2000	TCGA-OR-A5KU-01A-11D-A29I-10	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01	TCGA-OR-A5KU-01	49C334C1-C014-4BDD-817D-5BAF647C130C	TCGA-OR-A5KU-01A-11D-A29J-05	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01A-11D-A29H-01	TCGA-OR-A5KU-01	TCGA-OR-A5KU-01	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01A-11D-A29H-01	TCGA-OR-A5KU-01A-11D-A29I-10	TCGA-OR-A5KU-01A-11D-A29I-10
TCGA-OR-A5KV-01	0	TCGA-OR-A5KV-01	3878	0	days	TCGA-OR-A5KV	1116	1	days	3878	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	NO	NO	17	Atypical Mitotic Figures Present	TCGA-OR-A5KV-F60525	TCGA-OR-A5KV	TCGA-OR-A5KV-01A	M0	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Absent	-6250	3429		0	3878	1120	1116	Diffuse Architecture Absent		Biochemical Assessment	Androgen|Cortisol	2014-6-10	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Absent	NO	Left	NO	1				NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	1	true	No	N1	T2	Stage III	TCGA-OR-A5KV.D85CC5BA-0A85-4BCB-8088-9EBA37211501.pdf	A5KV	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2003	TCGA-OR-A5KV-01A-11D-A29I-10	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01	TCGA-OR-A5KV-01		TCGA-OR-A5KV-01A-11D-A29J-05	512b54a3-49c4-4dbd-b853-290500c00e81	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01A-11D-A29H-01	TCGA-OR-A5KV-01	TCGA-OR-A5KV-01	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01A-11D-A29H-01	TCGA-OR-A5KV-01A-11D-A29I-10	TCGA-OR-A5KV-01A-11D-A29I-10
TCGA-OR-A5KW-01	0	TCGA-OR-A5KW-01	2076	0	days	TCGA-OR-A5KW	2076	0	days	2076	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			55		TCGA-OR-A5KW-F60532	TCGA-OR-A5KW	TCGA-OR-A5KW-01A	M0	Retroperitoneal Lymph Node Involvement		-20328	1245		0	2076					Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	230		NO	Right	NO	9			10	YES	YES									NO		8	true	No	N1	T2	Stage III	TCGA-OR-A5KW.751F5B53-9186-4602-B824-8593E63EAC3F.pdf	A5KW	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING			2009	TCGA-OR-A5KW-01A-11D-A29I-10	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01	TCGA-OR-A5KW-01	767EAE99-8013-4CC9-ACA6-DCA18CD8A8D0	TCGA-OR-A5KW-01A-11D-A29J-05	64934de4-399f-4fbc-b283-979ab40addbc	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01A-11D-A29H-01	TCGA-OR-A5KW-01	TCGA-OR-A5KW-01	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01A-11D-A29H-01	TCGA-OR-A5KW-01A-11D-A29I-10	TCGA-OR-A5KW-01A-11D-A29I-10
TCGA-OR-A5KX-01	0	TCGA-OR-A5KX-01	1364	0	days	TCGA-OR-A5KX	62	1	days	1364	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	YES	25	Atypical Mitotic Figures Absent	TCGA-OR-A5KX-F60522	TCGA-OR-A5KX	TCGA-OR-A5KX-01A	M0	Normal	Cytoplasm presence <= 25% Present	-9298	914		0	1364	69	62	Diffuse Architecture Present				2014-6-10	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Present	NO	Left	NO					YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Pathology	Bone	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		true	No	N1	T2	Stage III	TCGA-OR-A5KX.02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4.pdf	A5KX	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2010	TCGA-OR-A5KX-01A-11D-A29I-10	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01	TCGA-OR-A5KX-01	C9B17637-359A-485E-9CA4-0E92B840CD03	TCGA-OR-A5KX-01A-11D-A29J-05	180a84c1-99c0-4014-b42e-8e01f88980aa	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01A-11D-A29H-01	TCGA-OR-A5KX-01	TCGA-OR-A5KX-01	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01A-11D-A29H-01	TCGA-OR-A5KX-01A-11D-A29I-10	TCGA-OR-A5KX-01A-11D-A29I-10
TCGA-OR-A5KY-01	1	TCGA-OR-A5KY-01	391	1	days	TCGA-OR-A5KY			days	391	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			23	Atypical Mitotic Figures Present		TCGA-OR-A5KY	TCGA-OR-A5KY-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-8745	939	391	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-5	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left		52	Imaging Suspected		5	YES	NO	YES	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						YES	Nuclear Grade III or IV Absent	52	true	No	N1	T4	Stage IV	TCGA-OR-A5KY.23328F06-11F8-4D12-BA95-D5CC9AEFE22A.pdf	A5KY	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent		YES	NO		NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2010	TCGA-OR-A5KY-01A-11D-A29I-10	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01	TCGA-OR-A5KY-01	75604E70-38A0-424C-97A9-4A1BA8F854CC	TCGA-OR-A5KY-01A-11D-A29J-05	bf4dc301-6b99-46c3-bdc4-d85905688e05	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01A-11D-A29H-01	TCGA-OR-A5KY-01	TCGA-OR-A5KY-01	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01A-11D-A29H-01	TCGA-OR-A5KY-01A-11D-A29I-10	TCGA-OR-A5KY-01A-11D-A29I-10
TCGA-OR-A5KZ-01	1	TCGA-OR-A5KZ-01	125	1	days	TCGA-OR-A5KZ			days	125	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			42	Atypical Mitotic Figures Absent		TCGA-OR-A5KZ	TCGA-OR-A5KZ-01A	M0	Normal	Cytoplasm presence <= 25% Present	-15594	319	125	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-11-7	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left						YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5KZ.22298C81-A72D-4E22-99DD-6541FB0953A4.pdf	A5KZ	WITH TUMOR	Persistent locoregional disease	YES		Progressive Disease	NO	RX		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2012	TCGA-OR-A5KZ-01A-11D-A29I-10	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01	TCGA-OR-A5KZ-01	5D348448-A293-4A3F-81F2-94BDD97B882D	TCGA-OR-A5KZ-01A-11D-A29J-05	6991a561-ff49-4546-9bc7-74cca88916ae	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01A-11D-A29H-01	TCGA-OR-A5KZ-01	TCGA-OR-A5KZ-01	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01A-11D-A29H-01	TCGA-OR-A5KZ-01A-11D-A29I-10	TCGA-OR-A5KZ-01A-11D-A29I-10
TCGA-OR-A5L1-01	0	TCGA-OR-A5L1-01	1781	0	days	TCGA-OR-A5L1			days	1781	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			37			TCGA-OR-A5L1	TCGA-OR-A5L1-01A	M0	Normal		-13840	4424		0	1781					Biochemical Assessment	Cortisol	2014-6-27	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160		NO	Left						YES	YES			Necrosis Present						YES			true	No	N0	T2	Stage II	TCGA-OR-A5L1.914A8783-5ACF-4580-A663-E73BDDAA7286.pdf	A5L1	WITH TUMOR		YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2000	TCGA-OR-A5L1-01A-11D-A30A-10								TCGA-OR-A5L1-01A-11D-A309-01				TCGA-OR-A5L1-01A-11D-A309-01	TCGA-OR-A5L1-01A-11D-A30A-10	TCGA-OR-A5L1-01A-11D-A30A-10
TCGA-OR-A5L2-01	1	TCGA-OR-A5L2-01	1852	1	days	TCGA-OR-A5L2	1852	0	days	1852	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			83	Atypical Mitotic Figures Present	TCGA-OR-A5L2-F61320	TCGA-OR-A5L2	TCGA-OR-A5L2-01A	M0	Normal		-30535	4313	1852	0								2014-6-26	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left	NO				30	NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO			true	No	N0	T2	Stage II	TCGA-OR-A5L2.A3E8E475-D5A7-4A4C-AA1D-3B3AE50F572B.pdf	A5L2	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED			2001	TCGA-OR-A5L2-01A-11D-A30A-10								TCGA-OR-A5L2-01A-11D-A309-01				TCGA-OR-A5L2-01A-11D-A309-01	TCGA-OR-A5L2-01A-11D-A30A-10	TCGA-OR-A5L2-01A-11D-A30A-10
TCGA-OR-A5L3-01	0	TCGA-OR-A5L3-01	4628	0	days	TCGA-OR-A5L3	4628	0	days	4628	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			67	Atypical Mitotic Figures Absent	TCGA-OR-A5L3-F60524	TCGA-OR-A5L3	TCGA-OR-A5L3-01A	M0	Normal	Cytoplasm presence <= 25% Absent	-24763	4591		0	4628			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T1	Stage I	TCGA-OR-A5L3.FE1CF238-753C-4DF4-A083-74DDC753DF45.pdf	A5L3	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2000	TCGA-OR-A5L3-01A-11D-A29I-10	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01	TCGA-OR-A5L3-01		TCGA-OR-A5L3-01A-11D-A29J-05	20f7acf8-7813-4ec8-af92-19f92d875a58	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01A-11D-A29H-01	TCGA-OR-A5L3-01	TCGA-OR-A5L3-01	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01A-11D-A29H-01	TCGA-OR-A5L3-01A-11D-A29I-10	TCGA-OR-A5L3-01A-11D-A29I-10
TCGA-OR-A5L4-01	0	TCGA-OR-A5L4-01	967	0	days	TCGA-OR-A5L4	967	0	days	967	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			48	Atypical Mitotic Figures Absent	TCGA-OR-A5L4-F60529	TCGA-OR-A5L4	TCGA-OR-A5L4-01A	M0	Normal	Cytoplasm presence <= 25% Present	-17819	456		0	967			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Right	NO					YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T4	Stage III	TCGA-OR-A5L4.B140F5B4-5B03-40EC-A5BB-BCF0963EC567.pdf	A5L4	TUMOR FREE	No imaging evidence of disease	YES		Complete Remission/Response	NO	RX		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	TCGA-OR-A5L4-01A-11D-A29I-10	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01	TCGA-OR-A5L4-01		TCGA-OR-A5L4-01A-11D-A29J-05	67affce9-7c50-46c9-9f1c-f80c1dd9c888	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01A-11D-A29H-01	TCGA-OR-A5L4-01	TCGA-OR-A5L4-01	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01A-11D-A29H-01	TCGA-OR-A5L4-01A-11D-A29I-10	TCGA-OR-A5L4-01A-11D-A29I-10
TCGA-OR-A5L5-01	0	TCGA-OR-A5L5-01	1317	0	days	TCGA-OR-A5L5	1317	0	days	1317	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			77	Atypical Mitotic Figures Absent	TCGA-OR-A5L5-F60530	TCGA-OR-A5L5	TCGA-OR-A5L5-01A	M0	Normal	Cytoplasm presence <= 25% Absent	-28270	828		0	1317			Diffuse Architecture Absent		Biochemical Assessment	Androgen|Estrogen	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Left	NO				15	NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	Yes	N0	T1	Stage I	TCGA-OR-A5L5.A1989B2E-FB1F-420A-BF11-2C79F3E81884.pdf	A5L5	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING	4		2010	TCGA-OR-A5L5-01A-11D-A29I-10	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01	TCGA-OR-A5L5-01		TCGA-OR-A5L5-01A-11D-A29J-05	2928fe95-b646-44a3-808a-36f0751c887b	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01A-11D-A29H-01	TCGA-OR-A5L5-01	TCGA-OR-A5L5-01	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01A-11D-A29H-01	TCGA-OR-A5L5-01A-11D-A29I-10	TCGA-OR-A5L5-01A-11D-A29I-10
TCGA-OR-A5L6-01	0	TCGA-OR-A5L6-01	861	0	days	TCGA-OR-A5L6	861	0	days	861	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			60	Atypical Mitotic Figures Absent	TCGA-OR-A5L6-F60528	TCGA-OR-A5L6	TCGA-OR-A5L6-01A	M0	Normal	Cytoplasm presence <= 25% Present	-22057	433		0	861			Diffuse Architecture Present		Biochemical Assessment	Androgen	2014-6-10	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Absent	NO	Left	NO				23	NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5L6.6104CA0C-86CD-46C9-A111-0024A75FB727.pdf	A5L6	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	TCGA-OR-A5L6-01A-11D-A29I-10	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01	TCGA-OR-A5L6-01		TCGA-OR-A5L6-01A-11D-A29J-05	68206c96-7d72-43e9-92c8-75f6b5a3f14c	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01A-11D-A29H-01	TCGA-OR-A5L6-01	TCGA-OR-A5L6-01	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01A-11D-A29H-01	TCGA-OR-A5L6-01A-11D-A29I-10	TCGA-OR-A5L6-01A-11D-A29I-10
TCGA-OR-A5L8-01	0	TCGA-OR-A5L8-01	885	0	days	TCGA-OR-A5L8	885	0	days	885	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			36	Atypical Mitotic Figures Absent	TCGA-OR-A5L8-F60527	TCGA-OR-A5L8	TCGA-OR-A5L8-01A	M0	Normal	Cytoplasm presence <= 25% Present	-13472	558		0	885			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Mineralocorticoids|Cortisol	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Right	NO					YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	No	N0	T2	Stage II	TCGA-OR-A5L8.C4BBFD0B-83D0-47C8-9662-13691FE6D820.pdf	A5L8	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	4	Venous Invasion Present	2011	TCGA-OR-A5L8-01A-11D-A29I-10	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01	TCGA-OR-A5L8-01		TCGA-OR-A5L8-01A-11D-A29J-05	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01A-11D-A29H-01	TCGA-OR-A5L8-01	TCGA-OR-A5L8-01	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01A-11D-A29H-01	TCGA-OR-A5L8-01A-11D-A29I-10	TCGA-OR-A5L8-01A-11D-A29I-10
TCGA-OR-A5L9-01	0	TCGA-OR-A5L9-01	871	0	days	TCGA-OR-A5L9	871	0	days	871	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			53	Atypical Mitotic Figures Absent	TCGA-OR-A5L9-F61321	TCGA-OR-A5L9		M0	Normal	Cytoplasm presence <= 25% Present	-19526			0	871			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen	2014-6-26	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES		Invasion of Tumor Capsule Absent		Right	NO	5			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present	0		No	N0	T2	Stage II		A5L9	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal		LIVING	3	Venous Invasion Absent	2011	TCGA-OR-A5L9-01A-11D-A29I-10	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01	TCGA-OR-A5L9-01		TCGA-OR-A5L9-01A-11D-A29J-05	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01A-11D-A29H-01	TCGA-OR-A5L9-01	TCGA-OR-A5L9-01	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01A-11D-A29H-01	TCGA-OR-A5L9-01A-11D-A29I-10	TCGA-OR-A5L9-01A-11D-A29I-10
TCGA-OR-A5LA-01	0	TCGA-OR-A5LA-01	719	0	days	TCGA-OR-A5LA	719	0	days	719	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			52	Atypical Mitotic Figures Absent	TCGA-OR-A5LA-F60533	TCGA-OR-A5LA	TCGA-OR-A5LA-01A	M0	Normal	Cytoplasm presence <= 25% Present	-19242	208		0	719			Diffuse Architecture Present			None	2014-6-10	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left	NO				1	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5LA.68F5B84D-8967-4A77-B5D9-65526AB9FFBB.pdf	A5LA	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2012	TCGA-OR-A5LA-01A-11D-A29I-10	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01	TCGA-OR-A5LA-01		TCGA-OR-A5LA-01A-11D-A29J-05	8e63ada3-97ca-46ab-984d-6a71a4e4e440	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01A-11D-A29H-01	TCGA-OR-A5LA-01	TCGA-OR-A5LA-01	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01A-11D-A29H-01	TCGA-OR-A5LA-01A-11D-A29I-10	TCGA-OR-A5LA-01A-11D-A29I-10
TCGA-OR-A5LB-01	1	TCGA-OR-A5LB-01	1204	1	days	TCGA-OR-A5LB			days	1204	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			59	Atypical Mitotic Figures Absent		TCGA-OR-A5LB	TCGA-OR-A5LB-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-21565	2386	1204	0				Diffuse Architecture Present	Vena cava and left atrium of the heart	Biochemical Assessment	Androgen	2013-11-4	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Right			Other, specify	Operation	8	YES		YES	Mitotic Rate > 5/50 HPF Present	Necrosis Absent						YES	Nuclear Grade III or IV Absent		true	Yes	N0	T4	Stage IV	TCGA-OR-A5LB.09038444-9BE4-443C-8FEC-07903972F305.pdf	A5LB	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	YES	R0		Primary Tumor	01	Sinusoid Invasion Present		YES	YES		NO	YES	OR	Adrenal	A	DECEASED	4	Venous Invasion Present	2006	TCGA-OR-A5LB-01A-11D-A29I-10	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01	TCGA-OR-A5LB-01		TCGA-OR-A5LB-01A-11D-A29J-05	881f6b71-7088-42c8-bfec-c86943715b56	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01A-11D-A29H-01	TCGA-OR-A5LB-01	TCGA-OR-A5LB-01	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01A-11D-A29H-01	TCGA-OR-A5LB-01A-11D-A29I-10	TCGA-OR-A5LB-01A-11D-A29I-10
TCGA-OR-A5LC-01	1	TCGA-OR-A5LC-01	159	1	days	TCGA-OR-A5LC			days	159	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			71	Atypical Mitotic Figures Absent		TCGA-OR-A5LC		M1	Liver Involvement	Cytoplasm presence <= 25% Absent	-26084		159	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2013-11-4	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Left			Biopsy Proven|Imaging Suspected			YES		YES	Mitotic Rate > 5/50 HPF Absent	Necrosis Present						YES	Nuclear Grade III or IV Absent			No	N0	T4	Stage IV		A5LC	WITH TUMOR	Persistent distant metastases	YES		Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent		NO			NO	YES	OR	Adrenal		DECEASED	3	Venous Invasion Present	2011	TCGA-OR-A5LC-01A-11D-A29I-10	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01	TCGA-OR-A5LC-01		TCGA-OR-A5LC-01A-11D-A29J-05	cbe8e9e4-f555-47ce-9905-d9f95637c18a	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01A-11D-A29H-01	TCGA-OR-A5LC-01	TCGA-OR-A5LC-01	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01A-11D-A29H-01	TCGA-OR-A5LC-01A-11D-A29I-10	TCGA-OR-A5LC-01A-11D-A29I-10
TCGA-OR-A5LD-01	1	TCGA-OR-A5LD-01	1197	1	days	TCGA-OR-A5LD			days	1197	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			52	Atypical Mitotic Figures Absent		TCGA-OR-A5LD	TCGA-OR-A5LD-01A	M0	Normal	Cytoplasm presence <= 25% Present	-19111	5280	1197	0				Diffuse Architecture Present			None	2013-11-7	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Absent	NO	Left						NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Absent		true	No	N0	T4	Stage III	TCGA-OR-A5LD.08D3F046-01AD-40B2-A4EC-1121366614CA.pdf	A5LD	WITH TUMOR	No imaging evidence of disease	NO	NO		NO	RX		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	5	Venous Invasion Absent	1998	TCGA-OR-A5LD-01A-11D-A29I-10	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01	TCGA-OR-A5LD-01	0AC0BCF3-1EC0-4DBB-A86D-3953B2F28AE8	TCGA-OR-A5LD-01A-11D-A29J-05	efd6520f-20a3-416b-87ce-6a1da0da448d	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01A-11D-A29H-01	TCGA-OR-A5LD-01	TCGA-OR-A5LD-01	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01A-11D-A29H-01	TCGA-OR-A5LD-01A-11D-A29I-10	TCGA-OR-A5LD-01A-11D-A29I-10
TCGA-OR-A5LE-01	1	TCGA-OR-A5LE-01	662	1	days	TCGA-OR-A5LE			days	662	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			14	Atypical Mitotic Figures Absent		TCGA-OR-A5LE		M0	Normal	Cytoplasm presence <= 25% Present	-5383		662	0				Diffuse Architecture Absent				2013-11-4	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Left						NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present			No	N0	T2	Stage II		A5LE	WITH TUMOR	No imaging evidence of disease	NO	YES		NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		DECEASED	5	Venous Invasion Absent	1997	TCGA-OR-A5LE-01A-11D-A29I-10	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01	TCGA-OR-A5LE-01		TCGA-OR-A5LE-01A-11D-A29J-05	d5597a19-f3ff-431b-85ba-d2f306fe2fab	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01A-11D-A29H-01	TCGA-OR-A5LE-01	TCGA-OR-A5LE-01	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01A-11D-A29H-01	TCGA-OR-A5LE-01A-11D-A29I-10	TCGA-OR-A5LE-01A-11D-A29I-10
TCGA-OR-A5LF-01	1	TCGA-OR-A5LF-01	445	1	days	TCGA-OR-A5LF	445	0	days	445	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			74	Atypical Mitotic Figures Absent		TCGA-OR-A5LF	TCGA-OR-A5LF-01A	M0	Normal	Cytoplasm presence <= 25% Present	-27179	3880	445	0				Diffuse Architecture Present			None	2014-6-27	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Present	NO	Left						NO			Mitotic Rate > 5/50 HPF Present	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	No	N0	T3	Stage III	TCGA-OR-A5LF.1E988E48-9FF4-4355-89CE-410CC1964D6C.pdf	A5LF	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	5	Venous Invasion Present	2002	TCGA-OR-A5LF-01A-11D-A30A-10								TCGA-OR-A5LF-01A-11D-A309-01				TCGA-OR-A5LF-01A-11D-A309-01	TCGA-OR-A5LF-01A-11D-A30A-10	TCGA-OR-A5LF-01A-11D-A30A-10
TCGA-OR-A5LG-01	0	TCGA-OR-A5LG-01	1589	0	days	TCGA-OR-A5LG			days	1589	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			46	Atypical Mitotic Figures Present		TCGA-OR-A5LG	TCGA-OR-A5LG-01A	M0	Normal	Cytoplasm presence <= 25% Present	-16875	1667		0	1589			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-11-5	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Left		1				YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Absent						YES	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage III	TCGA-OR-A5LG.DA704AB1-8D08-48EC-9F62-A6B5E69E4DC7.pdf	A5LG	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	RX		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2008	TCGA-OR-A5LG-01A-11D-A29I-10	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01	TCGA-OR-A5LG-01	3C264BFC-0334-4FE8-8523-279090AF04AA	TCGA-OR-A5LG-01A-11D-A29J-05	bdacf802-7670-445e-a1bc-1833c833940e	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01A-11D-A29H-01	TCGA-OR-A5LG-01	TCGA-OR-A5LG-01	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01A-11D-A29H-01	TCGA-OR-A5LG-01A-11D-A29I-10	TCGA-OR-A5LG-01A-11D-A29I-10
TCGA-OR-A5LH-01	1	TCGA-OR-A5LH-01	2385	1	days	TCGA-OR-A5LH	2385	0	days	2385	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			36	Atypical Mitotic Figures Present		TCGA-OR-A5LH	TCGA-OR-A5LH-01A	M0	Normal	Cytoplasm presence <= 25% Absent	-13182	2731	2385	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen	2013-11-5	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Absent	NO	Left					5	YES	YES		Mitotic Rate > 5/50 HPF Absent	Necrosis Present						NO	Nuclear Grade III or IV Absent		true	No	N0	T2	Stage II	TCGA-OR-A5LH.093D8D72-8D1B-4C23-A132-D0DCBB05DE26.pdf	A5LH	WITH TUMOR	Persistent distant metastases	YES	NO	Progressive Disease	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2005	TCGA-OR-A5LH-01A-11D-A29I-10	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01	TCGA-OR-A5LH-01	6BB4B44E-2E16-41BA-8811-66740A96C3F3	TCGA-OR-A5LH-01A-11D-A29J-05	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01A-11D-A29H-01	TCGA-OR-A5LH-01	TCGA-OR-A5LH-01	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01A-11D-A29H-01	TCGA-OR-A5LH-01A-11D-A29I-10	TCGA-OR-A5LH-01A-11D-A29I-10
TCGA-OR-A5LI-01	1	TCGA-OR-A5LI-01	436	1	days	TCGA-OR-A5LI	61	1	days	436	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	YES	42	Atypical Mitotic Figures Absent	TCGA-OR-A5LI-F61316	TCGA-OR-A5LI	TCGA-OR-A5LI-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-15536	5353	436	0			61	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-27	FEMALE	NO	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Right	NO		Imaging Suspected			NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Bone	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present		true	No	N0	T4	Stage IV	TCGA-OR-A5LI.087A53B3-572F-4492-8D19-7CFE41C8DA39.pdf	A5LI	WITH TUMOR	Persistent distant metastases	NO	NO	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Absent	1998	TCGA-OR-A5LI-01A-11D-A30A-10								TCGA-OR-A5LI-01A-11D-A309-01				TCGA-OR-A5LI-01A-11D-A309-01	TCGA-OR-A5LI-01A-11D-A30A-10	TCGA-OR-A5LI-01A-11D-A30A-10
TCGA-OR-A5LJ-01	1	TCGA-OR-A5LJ-01	1105	1	days	TCGA-OR-A5LJ			days	1105	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			54	Atypical Mitotic Figures Present		TCGA-OR-A5LJ	TCGA-OR-A5LJ-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-20069	2633	1105	0				Diffuse Architecture Present	Lymph nodes	Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-7	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left			Imaging Suspected		10	YES	YES	YES	Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present		true	No	N1	T2	Stage IV	TCGA-OR-A5LJ.B93073AF-A15A-4BAB-AC70-E16D89256DFC.pdf	A5LJ	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2005	TCGA-OR-A5LJ-01A-11D-A29I-10	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01	TCGA-OR-A5LJ-01	E6673A36-9456-4788-8E0A-FED99D1849B9	TCGA-OR-A5LJ-01A-11D-A29J-05	744e863c-e24e-4eee-b0ee-ee24f2ef7401	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01A-11D-A29H-01	TCGA-OR-A5LJ-01	TCGA-OR-A5LJ-01	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01A-11D-A29H-01	TCGA-OR-A5LJ-01A-11D-A29I-10	TCGA-OR-A5LJ-01A-11D-A29I-10
TCGA-OR-A5LK-01	0	TCGA-OR-A5LK-01	2740	0	days	TCGA-OR-A5LK	2740	0	days	2740	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			62	Atypical Mitotic Figures Absent	TCGA-OR-A5LK-F71750	TCGA-OR-A5LK	TCGA-OR-A5LK-01A	M0	Normal	Cytoplasm presence <= 25% Present	-22919	2096		0	2740			Diffuse Architecture Present			None	2015-3-30	MALE	NO		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Absent	NO	Right	NO				7	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5LK.4917D13C-6355-4E4B-8189-FE4443313F53.pdf	A5LK	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2007	TCGA-OR-A5LK-01A-11D-A29I-10	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01	TCGA-OR-A5LK-01	4706C9EA-9C64-4CFA-A727-C371EE8CAAC8	TCGA-OR-A5LK-01A-11D-A29J-05	6bce4f20-babf-4cbd-a962-6b977986e19d	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01A-11D-A29H-01	TCGA-OR-A5LK-01	TCGA-OR-A5LK-01	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01A-11D-A29H-01	TCGA-OR-A5LK-01A-11D-A29I-10	TCGA-OR-A5LK-01A-11D-A29I-10
TCGA-OR-A5LL-01	1	TCGA-OR-A5LL-01	1613	1	days	TCGA-OR-A5LL			days	1613	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			75	Atypical Mitotic Figures Present		TCGA-OR-A5LL	TCGA-OR-A5LL-01A	M0	Normal	Cytoplasm presence <= 25% Present	-27607	1882	1613	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-27	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Right		10			15	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5LL.A898F0C7-9596-4DF1-9784-CAACFAB672D8.pdf	A5LL	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	DECEASED	7	Venous Invasion Absent	2007	TCGA-OR-A5LL-01A-11D-A29I-10	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01	TCGA-OR-A5LL-01	6E7DE852-5C21-4694-9B99-22FE8D927A7F	TCGA-OR-A5LL-01A-11D-A29J-05	63f6ab7c-2ef7-42a3-afda-0289383a6976	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01A-11D-A29H-01	TCGA-OR-A5LL-01	TCGA-OR-A5LL-01	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01A-11D-A29H-01	TCGA-OR-A5LL-01A-11D-A29I-10	TCGA-OR-A5LL-01A-11D-A29I-10
TCGA-OR-A5LM-01	0	TCGA-OR-A5LM-01	1858	0	days	TCGA-OR-A5LM	1858	0	days	1858	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			23	Atypical Mitotic Figures Present	TCGA-OR-A5LM-F71749	TCGA-OR-A5LM	TCGA-OR-A5LM-01A	M0	Normal	Cytoplasm presence <= 25% Present	-8735	1821		0	1858			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Estrogen	2015-3-30	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	32			18	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5LM.57A7E2E6-210B-41B1-8C22-9ED4930BCDEA.pdf	A5LM	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Absent	2008	TCGA-OR-A5LM-01A-11D-A29I-10	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	TCGA-OR-A5LM-01	TCGA-OR-A5LM-01	8B5ED987-A6A4-4BEB-852A-E10F4CF37A30	TCGA-OR-A5LM-01A-11D-A29J-05	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	TCGA-OR-A5LM-01A-11D-A29H-01	TCGA-OR-A5LM-01	TCGA-OR-A5LM-01	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	TCGA-OR-A5LM-01A-11D-A29H-01		
TCGA-OR-A5LN-01	0	TCGA-OR-A5LN-01	2342	0	days	TCGA-OR-A5LN	2342	0	days	2342	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			31	Atypical Mitotic Figures Present	TCGA-OR-A5LN-F71751	TCGA-OR-A5LN	TCGA-OR-A5LN-01A	M0	Normal	Cytoplasm presence <= 25% Present	-11414	1790		0	2342			Diffuse Architecture Present			None	2015-3-30	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	10			6	NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Absent						NO	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5LN.92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169.pdf	A5LN	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2008	TCGA-OR-A5LN-01A-11D-A29I-10	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01	TCGA-OR-A5LN-01	AEE4D7BD-057F-4C4A-9544-2527784CBD29	TCGA-OR-A5LN-01A-11D-A29J-05	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01A-11D-A29H-01	TCGA-OR-A5LN-01	TCGA-OR-A5LN-01	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01A-11D-A29H-01	TCGA-OR-A5LN-01A-11D-A29I-10	TCGA-OR-A5LN-01A-11D-A29I-10
TCGA-OR-A5LO-01	1	TCGA-OR-A5LO-01	2405	1	days	TCGA-OR-A5LO	153	1	days	2405	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	YES	61	Atypical Mitotic Figures Present	TCGA-OR-A5LO-F71748	TCGA-OR-A5LO	TCGA-OR-A5LO-01A	M0	Normal	Cytoplasm presence <= 25% Present	-22370	1700	2405	0	1949	1309	153	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Estrogen	2015-3-30	FEMALE	NO	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	170	Invasion of Tumor Capsule Present	NO	Right	NO	19			12	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5LO.45C2478C-53EF-4422-A9EF-33C40A3AA275.pdf	A5LO	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	DECEASED	7	Venous Invasion Absent	2008	TCGA-OR-A5LO-01A-11D-A29I-10	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01	TCGA-OR-A5LO-01	51B5F64E-06A8-48C6-AD83-B7006B707D55	TCGA-OR-A5LO-01A-11D-A29J-05	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01A-11D-A29H-01	TCGA-OR-A5LO-01	TCGA-OR-A5LO-01	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01A-11D-A29H-01	TCGA-OR-A5LO-01A-11D-A29I-10	TCGA-OR-A5LO-01A-11D-A29I-10
TCGA-OR-A5LP-01	0	TCGA-OR-A5LP-01	1857	0	days	TCGA-OR-A5LP	1857	0	days	1857	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			37	Atypical Mitotic Figures Absent	TCGA-OR-A5LP-F59578	TCGA-OR-A5LP	TCGA-OR-A5LP-01A	M0	Normal	Cytoplasm presence <= 25% Present	-13574	1396		0	1857			Diffuse Architecture Present			None	2014-5-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	21			0	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Present	0	true	No	N0	T2	Stage II	TCGA-OR-A5LP.FCD998EA-2EEA-4A94-80A6-D87F962BBC87.pdf	A5LP	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2009	TCGA-OR-A5LP-01A-11D-A29I-10	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01	TCGA-OR-A5LP-01	7D9FD532-600B-4BF1-987D-ADAA2895F9AB	TCGA-OR-A5LP-01A-11D-A29J-05	62428588-d744-40ee-9318-f09c64e95898	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01A-11D-A29H-01	TCGA-OR-A5LP-01	TCGA-OR-A5LP-01	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01A-11D-A29H-01	TCGA-OR-A5LP-01A-11D-A29I-10	TCGA-OR-A5LP-01A-11D-A29I-10
TCGA-OR-A5LR-01	0	TCGA-OR-A5LR-01	853	0	days	TCGA-OR-A5LR	853	0	days	853	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			30	Atypical Mitotic Figures Present	TCGA-OR-A5LR-F59581	TCGA-OR-A5LR	TCGA-OR-A5LR-01A	M0	Normal	Cytoplasm presence <= 25% Present	-11261	482		0	853			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Mineralocorticoids	2014-5-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Present	NO	Left	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5LR.A1C555F3-4513-45C6-9A39-968902130B94.pdf	A5LR	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Absent	2011	TCGA-OR-A5LR-01A-11D-A29I-10	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01	TCGA-OR-A5LR-01		TCGA-OR-A5LR-01A-11D-A29J-05	70b87c96-d585-4260-aa9a-7a5ee37d1b10	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01A-11D-A29H-01	TCGA-OR-A5LR-01	TCGA-OR-A5LR-01	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01A-11D-A29H-01	TCGA-OR-A5LR-01A-11D-A29I-10	TCGA-OR-A5LR-01A-11D-A29I-10
TCGA-OR-A5LS-01	0	TCGA-OR-A5LS-01	1096	0	days	TCGA-OR-A5LS	1096	0	days	1096	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			34	Atypical Mitotic Figures Absent	TCGA-OR-A5LS-F59579	TCGA-OR-A5LS	TCGA-OR-A5LS-01A	M0	Normal	Cytoplasm presence <= 25% Present	-12663	725		0	1096			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	100	Invasion of Tumor Capsule Absent	NO	Right	NO				7	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		true	No	N0	T2	Stage II	TCGA-OR-A5LS.31004530-E017-4913-A8AA-7AE709EAE0F1.pdf	A5LS	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2011	TCGA-OR-A5LS-01A-11D-A29I-10	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01	TCGA-OR-A5LS-01	9F4DFEE6-3193-44C2-98BE-6649DB11A67C	TCGA-OR-A5LS-01A-11D-A29J-05	67a0828e-86c3-4c46-b05c-104000425669	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01A-11D-A29H-01	TCGA-OR-A5LS-01	TCGA-OR-A5LS-01	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01A-11D-A29H-01	TCGA-OR-A5LS-01A-11D-A29I-10	TCGA-OR-A5LS-01A-11D-A29I-10
TCGA-OR-A5LT-01	0	TCGA-OR-A5LT-01	549	0	days	TCGA-OR-A5LT	549	0	days	549	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			57	Atypical Mitotic Figures Present	TCGA-OR-A5LT-F59582	TCGA-OR-A5LT	TCGA-OR-A5LT-01A	M0	Normal	Cytoplasm presence <= 25% Present	-21032	178		0	549			Diffuse Architecture Present			None	2014-5-15	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left	NO	18			10	YES	YES		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present	0	true	No	N0	T3	Stage III	TCGA-OR-A5LT.6C9B7DE2-682F-4F4A-8879-159F9989C40C.pdf	A5LT	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	8	Venous Invasion Present	2012	TCGA-OR-A5LT-01A-11D-A29I-10	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01	TCGA-OR-A5LT-01	88870133-85F4-49A2-92D1-12E92055C7E7	TCGA-OR-A5LT-01A-11D-A29J-05	c18bba08-b10a-4237-96a6-5f89efa59826	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01A-11D-A29H-01	TCGA-OR-A5LT-01	TCGA-OR-A5LT-01	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01A-11D-A29H-01	TCGA-OR-A5LT-01A-11D-A29I-10	TCGA-OR-A5LT-01A-11D-A29I-10
TCGA-OU-A5PI-01	0	TCGA-OU-A5PI-01	1171	0	days	TCGA-OU-A5PI	351	1	days	1171	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland	YES	YES	53	Atypical Mitotic Figures Absent	TCGA-OU-A5PI-F65711	TCGA-OU-A5PI	TCGA-OU-A5PI-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-19492	577		0	1171	384	351	Diffuse Architecture Absent			None	2014-9-29	FEMALE	YES	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left	NO	3	Other, specify	Resection		YES	YES	NO	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Absent	3	false	No	N1	T2	Stage IV	TCGA-OU-A5PI.2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4.pdf	A5PI	WITH TUMOR	Persistent distant metastases	YES	YES	Stable Disease	NO		RET Negative	Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OU	Adrenal	A	LIVING	2	Venous Invasion Absent	2011	TCGA-OU-A5PI-01A-12D-A29I-10	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01	TCGA-OU-A5PI-01	A6D0B6AB-D7DE-4233-805C-E85505D0BE77	TCGA-OU-A5PI-01A-12D-A29J-05	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01A-12D-A29H-01	TCGA-OU-A5PI-01	TCGA-OU-A5PI-01	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01A-12D-A29H-01	TCGA-OU-A5PI-01A-12D-A29I-10	TCGA-OU-A5PI-01A-12D-A29I-10
TCGA-P6-A5OF-01	1	TCGA-P6-A5OF-01	207	1	days	TCGA-P6-A5OF			days	207	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			55			TCGA-P6-A5OF		M0	Vena Cava Involvement/thrombus		-20106		207	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-8-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES				Right						NO			Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present			No	N0	T4	Stage III		A5OF	WITH TUMOR	Persistent distant metastases	NO	NO		NO	RX		Primary Tumor	01						NO	YES	P6	Adrenal		DECEASED	4	Venous Invasion Present	2010	TCGA-P6-A5OF-01A-11D-A29I-10	ca5f547a-8ec9-4436-9878-1f1cab2fa329	TCGA-P6-A5OF-01	TCGA-P6-A5OF-01		TCGA-P6-A5OF-01A-11D-A29J-05	ca5f547a-8ec9-4436-9878-1f1cab2fa329	ca5f547a-8ec9-4436-9878-1f1cab2fa329		TCGA-P6-A5OF-01		ca5f547a-8ec9-4436-9878-1f1cab2fa329		TCGA-P6-A5OF-01A-11D-A29I-10	TCGA-P6-A5OF-01A-11D-A29I-10
TCGA-P6-A5OG-01	1	TCGA-P6-A5OG-01	383	1	days	TCGA-P6-A5OG			days	383	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			45	Atypical Mitotic Figures Absent		TCGA-P6-A5OG	TCGA-P6-A5OG-01A	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-16659	426	383	0				Diffuse Architecture Absent		Biochemical Assessment	Cortisol	2013-8-15	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Present	NO	Left		6	Biopsy Proven			NO			Mitotic Rate > 5/50 HPF Absent	Necrosis Present						YES	Nuclear Grade III or IV Present	0	false	Yes	N0	T4	Stage IV	TCGA-P6-A5OG.4F591001-D8B2-4B68-A219-45EBA6903A80.pdf	A5OG	WITH TUMOR	Persistent distant metastases	NO	YES	Complete Remission/Response	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	P6	Adrenal	A	DECEASED	4	Venous Invasion Absent	2011	TCGA-P6-A5OG-01A-22D-A29I-10	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564			18B5333E-0649-4BBB-9271-5779C2D13BC8	TCGA-P6-A5OG-01A-22D-A29J-05	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	TCGA-P6-A5OG-01A-22D-A29H-01	TCGA-P6-A5OG-01	TCGA-P6-A5OG-01	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	TCGA-P6-A5OG-01A-22D-A29H-01	TCGA-P6-A5OG-01A-22D-A29I-10	TCGA-P6-A5OG-01A-22D-A29I-10
TCGA-P6-A5OH-01	1	TCGA-P6-A5OH-01	0	1	days	TCGA-P6-A5OH	0	0	days	0	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			59			TCGA-P6-A5OH	TCGA-P6-A5OH-01A	M1		Cytoplasm presence <= 25% Present	-21627	1021	0	0				Diffuse Architecture Present				2014-3-25	FEMALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200		NO	Right			Biopsy Proven			NO				Necrosis Present						NO	Nuclear Grade III or IV Present		false	No	N0	T4	Stage IV	TCGA-P6-A5OH.349F5609-E653-4CF0-B63C-AF01D68D40E7.pdf	A5OH	WITH TUMOR		NO			NO	R2		Primary Tumor	01						NO	YES	P6	Adrenal	A	DECEASED	4		2010	TCGA-P6-A5OH-01A-11D-A30A-10								TCGA-P6-A5OH-01A-11D-A309-01				TCGA-P6-A5OH-01A-11D-A309-01	TCGA-P6-A5OH-01A-11D-A30A-10	TCGA-P6-A5OH-01A-11D-A30A-10
TCGA-PA-A5YG-01	0	TCGA-PA-A5YG-01	756	0	days	TCGA-PA-A5YG	756	0	days	756	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			51		TCGA-PA-A5YG-F69304	TCGA-PA-A5YG	TCGA-PA-A5YG-01A	M0	Normal		-18926	85		0	756							2014-12-31	MALE	NO		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	440		NO	Left	NO					NO	NO									NO			true	No	N0	T2	Stage II	TCGA-PA-A5YG.9C523464-BFDB-4C7A-972E-2EBECDBBFF3E.pdf	A5YG	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01						YES	NO	PA	Adrenal	A	LIVING			2012	TCGA-PA-A5YG-01A-11D-A29I-10	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01	TCGA-PA-A5YG-01	78AB014F-E03C-4109-9348-34862B626270	TCGA-PA-A5YG-01A-11D-A29J-05	379e288c-fa30-460c-bb57-d3b6f09b1483	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01A-11D-A29H-01	TCGA-PA-A5YG-01	TCGA-PA-A5YG-01	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01A-11D-A29H-01	TCGA-PA-A5YG-01A-11D-A29I-10	TCGA-PA-A5YG-01A-11D-A29I-10
TCGA-PK-A5H8-01	0	TCGA-PK-A5H8-01	3623	0	days	TCGA-PK-A5H8	3623	0	days	3623	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			42	Atypical Mitotic Figures Present	TCGA-PK-A5H8-F65384	TCGA-PK-A5H8	TCGA-PK-A5H8-01A	M0		Cytoplasm presence <= 25% Present	-15373	3025		0	3623			Diffuse Architecture Present				2014-9-22	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	210	Invasion of Tumor Capsule Absent	NO	Right	NO				9		NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present		false	No	N0	T2	Stage II	TCGA-PK-A5H8.706EC715-C6CD-49A9-8993-D6E5B20AED95.pdf	A5H8	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	PK	Adrenal	A	LIVING	7	Venous Invasion Present	2004	TCGA-PK-A5H8-01A-11D-A29I-10	cdb932bf-d02c-4c3c-9e71-22eb12623977	TCGA-PK-A5H8-01	TCGA-PK-A5H8-01	E8C935A8-A842-414D-9E8A-AF40D7BE64A9	TCGA-PK-A5H8-01A-11D-A29J-05	cdb932bf-d02c-4c3c-9e71-22eb12623977	cdb932bf-d02c-4c3c-9e71-22eb12623977		TCGA-PK-A5H8-01		cdb932bf-d02c-4c3c-9e71-22eb12623977		TCGA-PK-A5H8-01A-11D-A29I-10	TCGA-PK-A5H8-01A-11D-A29I-10
TCGA-PK-A5H9-01	0	TCGA-PK-A5H9-01	616	0	days	TCGA-PK-A5H9	616	0	days	616	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			27	Atypical Mitotic Figures Present	TCGA-PK-A5H9-F62621	TCGA-PK-A5H9	TCGA-PK-A5H9-01A	M0		Cytoplasm presence <= 25% Present	-10173	92		0	616			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2014-8-11	FEMALE	YES		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	90	Invasion of Tumor Capsule Absent	NO	Right	NO				2	NO	NO		Mitotic Rate > 5/50 HPF Absent	Necrosis Absent						NO	Nuclear Grade III or IV Absent		false	No	N0	T2	Stage II	TCGA-PK-A5H9.A323FD5A-1C3E-49D3-A7EA-04E3663D6883.pdf	A5H9	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	PK	Adrenal	A	LIVING	4	Venous Invasion Present	2012	TCGA-PK-A5H9-01A-11D-A29I-10	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01	TCGA-PK-A5H9-01	52E291F2-445C-4088-88AD-04034A488599	TCGA-PK-A5H9-01A-11D-A29J-05	207683b6-6a60-44ef-8eb2-d26ed9a7de76	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01A-11D-A29H-01	TCGA-PK-A5H9-01	TCGA-PK-A5H9-01	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01A-11D-A29H-01	TCGA-PK-A5H9-01A-11D-A29I-10	TCGA-PK-A5H9-01A-11D-A29I-10
TCGA-PK-A5HA-01	0	TCGA-PK-A5HA-01	1201	0	days	TCGA-PK-A5HA	1201	0	days	1201	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			63	Atypical Mitotic Figures Present	TCGA-PK-A5HA-F62620	TCGA-PK-A5HA	TCGA-PK-A5HA-01A	M0		Cytoplasm presence <= 25% Present	-23345	701		0	1201			Diffuse Architecture Present			None	2014-8-11	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Left	NO	1				NO	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						NO	Nuclear Grade III or IV Present	0	false	No	N0	T1	Stage I	TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00.pdf	A5HA	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	PK	Adrenal	A	LIVING	8	Venous Invasion Absent	2011	TCGA-PK-A5HA-01A-11D-A29I-10	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01	TCGA-PK-A5HA-01	85DDE23B-20FB-450B-9D82-609D7F4C6207	TCGA-PK-A5HA-01A-11D-A29J-05	69d7a879-cf23-44d0-8a44-050b7a3f4b03	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01A-11D-A29H-01	TCGA-PK-A5HA-01	TCGA-PK-A5HA-01	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01A-11D-A29H-01	TCGA-PK-A5HA-01A-11D-A29I-10	TCGA-PK-A5HA-01A-11D-A29I-10
TCGA-PK-A5HB-01	0	TCGA-PK-A5HB-01	1293	0	days	TCGA-PK-A5HB			days	1293	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			63			TCGA-PK-A5HB					-23293			0	1293							2013-9-16	MALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES				Left		2				NO										YES				Yes					A5HB	WITH TUMOR		YES	YES		YES			Primary Tumor	01						NO	YES	PK	Adrenal		LIVING			2003	TCGA-PK-A5HB-01A-11D-A29I-10	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01	TCGA-PK-A5HB-01		TCGA-PK-A5HB-01A-11D-A29J-05	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01A-11D-A29H-01	TCGA-PK-A5HB-01	TCGA-PK-A5HB-01	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01A-11D-A29H-01	TCGA-PK-A5HB-01A-11D-A29I-10	TCGA-PK-A5HB-01A-11D-A29I-10
TCGA-PK-A5HC-01	0	TCGA-PK-A5HC-01	679	0	days	TCGA-PK-A5HC			days	679	days	TCGA Adrenocortical Cancer (ACC)	adrenocortical cancer	Adrenal gland			44			TCGA-PK-A5HC	TCGA-PK-A5HC-01A	M0	Vena Cava Involvement/thrombus	Cytoplasm presence <= 25% Present	-16182	359		0	679			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-3-13	FEMALE			Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right		3			19	YES	NO		Mitotic Rate > 5/50 HPF Present	Necrosis Present						YES	Nuclear Grade III or IV Present	0	false	No	N0	T4	Stage III	TCGA-PK-A5HC.760C639D-B101-441C-8081-30908D56EDA2.pdf	A5HC	WITH TUMOR	No imaging evidence of disease	NO	YES	Complete Remission/Response	NO	R1		Primary Tumor	01	Sinusoid Invasion Present		YES	YES		NO	YES	PK	Adrenal	A	LIVING	9	Venous Invasion Present	2011	TCGA-PK-A5HC-01A-11D-A30A-10								TCGA-PK-A5HC-01A-11D-A309-01				TCGA-PK-A5HC-01A-11D-A309-01	TCGA-PK-A5HC-01A-11D-A30A-10	TCGA-PK-A5HC-01A-11D-A30A-10
